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Introduction 
Physiological background 
 
Oxygen is one of the major essential components required for sustaining life. Under 
physiologic conditions pulmonary ventilation provides oxygen for the body through the 
respiratory tree to the alveoli. During alveolar ventilation oxygen diffuses through the 
respiratory membrane from the alveoli to the pulmonary blood. Oxygen is transported to the 
tissues in chemical combination with hemoglobin in the red blood cells and in the dissolved 
state. Were it not for the hemoglobin molecule only a small fraction of oxygen could be 
transported.  
Hemoglobin consists of four chains and 
each has an atom of iron with which one 
molecule of oxygen loosely and reversibly binds. 
In 100 millilitres of blood there is 15 grams of 
hemoglobin. Each gram of hemoglobin may bind 
with a maximum of 1.34 (1.39 when chemically 
pure) millilitres of oxygen, thus in 100 millilitres 
of blood there is ~ 20 millilitres of oxygen bound 
when the hemoglobin saturation is 100 per cent. Under normal circumstances ~ 4 ml/kg/min 
of oxygen is consumed by the tissues to ensure aerobic energy release in the cells.   
As oxygen is used up by the cells, carbon 
dioxide is produced. Transport of carbon dioxide 
takes place in exactly the opposite direction as 
that of oxygen. In each 100 millilitres of blood ~ 
4 ml of carbon dioxide is transported from the 
cells towards the pulmonary capillaries in three 
forms; in the dissolved state, as bicarbonate ion 
and bound to hemoglobin. Carbon dioxide is 
transported from the cells to the alveoli where the excess amount of it is exhaled.1  
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Critically Ill     
 
 Tissue oxygenation is determined by the balance between the rate of oxygen transport 
to the tissues (oxygen delivery) and the rate at which the oxygen is used by the tissues 
(oxygen consumption). Standard formulae to determine oxygen delivery and oxygen 
consumption are the following:  
 
( )( ) ( )
( )( )( ) ( )
2 2 2 2
2 2 2 2 2 2
DO SV HR Hb 1.34 SaO 0.003 PaO CO CaO
VO CO CaO Hb 1.34 SvO 0.003 PvO CO CaO CvO−
= ∗ ∗ ∗ ∗ + ∗ = ∗
= ∗ − ∗ ∗ + ∗ = ∗
 
 
DO2 - oxygen delivery, SV – stroke volume, HR – heart rate, Hb – hemoglobin, SaO2 – 
arterial hemoglobin oxygen saturation, PaO2 – arterial oxygen partial pressure, CO – cardiac 
output, CaO2 – arterial oxygen content, VO2 – oxygen consumption, SvO2 – mixed venous 
hemoglobin oxygen saturation, PvO2 – venous oxygen partial pressure, CvO2 – venous 
oxygen content      
  
From the above formulae one can calculate the oxygen delivery at rest: 
 
( ) ( )2
2
CO 70 mL 72/min 5 L/min
CaO 150 g/L 1.34 mL 0.003  mm Hg .30 mL/L
DO mL/min
= ∗ =
= ∗ ∗1 + ∗100 = 201
∼1000 
 
 
Oxygen consumption at rest: 
  
( ) ( )
( )
2
2
CvO 150 g/L 1.34 mL 0.003  mm Hg .87 mL/L
VO L/min 201.30 mL/L 150.87 mL/L mL/min
= ∗ ∗0.75 + ∗40 =150
= 5 ∗ − ∼ 250 
  
 
Oxygen extraction ( )2 2VO /DO 100 250 mL/min 1000 mL/min 100 25∗ = / ∗ = %   
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In the critically ill there is often an imbalance between oxygen delivery and 
consumption.2,3,4 Oxygen delivery may be inadequate based on two grounds; arterial oxygen 
content and/or cardiac output may be reduced.  
 
One of the most common causes of decreased arterial oxygen content in the critically 
ill is anemia.5 The prevalence of anemia among critically ill patients could be as high as 95 % 
by day three. A number of guidelines are of help in transfusion practice, however the criteria 
for the optimal management of anemia are not clearly defined. 6,7 In most guidelines the 
transfusion trigger, i.e. the indication and timing of blood transfusion, is a certain level of 
hemoglobin, usually 70-100 g/L.8,9,10 It was recently suggested that hemoglobin level should 
not be the only factor on which the indication of blood transfusion is based.8,9 There is 
increasing evidence that transfusion is a double-edged sword: untreated anemia can be 
associated with a worse outcome and increased mortality, while transfusion may cause 
various infectious and non-infectious adverse effects.11-13 There is a clear need for additional 
quantitative parameters that would give information on anemia related altered oxygen 
extraction and hence the need for blood administration.9,14  
A common cause for decreased cardiac output in the intensive care unit is 
hypovolemia. Diagnosing hypovolemia is an everyday challenge in critical care. Clinicians 
utilize a large array of tools from simple clinical signs to invasive hemodynamic 
measurements, but a universally accepted gold standard parameter remains elusive.15 
Although, diagnosis may prove difficult, early recognition of hypovolemia is of utmost 
importance. By the time macro-hemodynamic changes manifest, the microcirculation may 
already be damaged.16-18 Furthermore, fluid therapy is ambiguous, on the one hand fluid 
resuscitation can save lives, but on the other hand a cumulative positive fluid balance is an 
independent risk factor for mortality.19,20 Deciding on the level of monitoring (non-invasive, 
‘less’ invasive, invasive), and which parameter to monitor in order to keep the critically ill 
patient normovolemic remains uncertain.     
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Central venous oxygen saturation (ScvO2), the hemoglobin oxygen saturation 
measured in a central vein, is a potentially useful physiological parameter. It is easily obtained 
as a blood gas sample from the vena cava superior via the central venous catheter already in 
situ in most critically ill patients. The main factors influencing ScvO2 are hemoglobin, arterial 
oxygen saturation of hemoglobin, cardiac output and oxygen consumption. Its normal value 
varies between 73-82 %. Although, the value reflects the oxygen extraction of the brain and 
the upper extremities, it is considered a reasonable surrogate marker of mixed-venous oxygen 
saturation (SvO2) – the parameter representing the whole body oxygen extraction - in the 
clinical setting. Thence, it is often used as a marker of the balance between oxygen delivery 
and consumption. 14,21-24  
Changes in ScvO2 reflect systemic oxygen metabolism, but may fail to detect regional 
hypoxia and may also be false-negative when >70%. Under these conditions the central 
venous-to-arterial carbon dioxide difference (CO2-gap) has been proposed as an alternative. It 
is as easily obtained as ScvO2, only a simultaneous arterial and central venous blood gas 
sampling is needed. The physiological threshold of CO2-gap is <5 mmHg, but this may be 
higher in low flow states. A concept based on the CO2 stagnation phenomenon considers the 
cause of an increased CO2-gap to be low blood flow, and an inverse correlation was found 
between CO2-gap and CO in non-septic and septic circulatory failures. Moreover, literature 
findings indicate that the amount of CO2 produced is negligible when anaerobic respiration is 
present and therefore CO2-gap cannot serve as a marker of tissue hypoxia.25-28  
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Our aims were the following: 
 
 
 
1. To evaluate the change in ScvO2 before and after transfusion in a retrospective study 
and to test whether the combination of Hb and ScvO2 may reflect anemia caused 
altered oxygen balance better than Hb alone. 
 
2. To monitor the changes of ScvO2 in isovolemic anemia using a large animal model 
and test whether an altered VO2/DO2 balance, which is due solely to a decreased Hb 
level, can be detected by ScvO2. 
 
3. To investigate how CO2-gap changes during experimental isovolemic anemia and how 
it contributes to ScvO2.   
 
4. To determine the effect of hypovolemia on ScvO2 and CO2-gap and the association 
between ScvO2, CO2-gap and indicators of microcirculatory blood flow. 
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ScvO2 
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1. Changes in ScvO2 before and after transfusion -  a retrospective study 
 
1.1. Materials and Methods 
 
This retrospective study was conducted in four intensive care units of the University of 
Szeged over a six month period. 
   
All the patients who received blood transfusions were searched via the medical network 
system. Only those patients were included in the study who had arterial and central venous 
blood gas analysis before and after transfusion. The parameters of interest were: hemoglobin, 
ScvO2, arterial oxygen saturation of haemoglobin (SaO2), mean arterial pressure (MAP), heart 
rate (HR), central venous pressure (CVP), lactate and the simplified oxygen extraction ratio 
(ERO2).  
The standard formula for ERO2 is: (SaO2 - ScvO2)/ SaO2 x 100.  
Data are reported as medians (interquartile ranges), unless indicated otherwise. To test 
for normal distribution the Kolmogorov-Smirnov test was used. For between-groups analysis 
the Mann-Whitney test and for before-after comparison the Wilcoxon test were used. For 
statistical analysis SPSS version 18.0 for Windows (SPSS, Chicago, IL) was used and p<.05 
was considered statistically significant. 
 
1.2. Results 
  
Over the study period 128 transfusion events were recorded of which ScvO2 was 
measured in 50 events in 41 patients. The data of these 41 patients were included in further 
analysis. Demographics are summarised in Table 1.  
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Table 1
 Demographic data 
Patient number 41
Age (ys) 63(49-73)
Gender (m/f) 27/14
Survival (y/n) 26/15
ICU stay (days) 7(3-13)
Major diagnosis: 
postoperative 22
sepsis 7
observation 6
pneumonia 6
 
After transfusion Hb levels increased significantly, which was accompanied by 
significant changes in all the other parameters but SaO2 (Table 2).  
 
Table 2 Before and after transfusion
Before After
Hb (g/L) 7.7(7.1-8.2) 9.1(7.9-9.7)*
ScvO2 (%) 67(60-76) 75(69-80)*
SaO2 (%) 99(95-99) 99(98-100)
MAP (mmHg) 72(65-80) 80(71-90)*
HR (beat/min) 100(90- 90(80-109)*
CVP mmHg) 8(4-10) 9(7-11)*
Lactate (mmol/L) 1.1(0.9-2.2) 0.9(0.6-2.1)*
ERO2 (%) 31(22-39) 22(19-28)*
  
*p <.05 Wilcoxon test. 
 
The median ScvO2 was 71%, therefore we divided the patients into two groups:  low 
group (LG, ScvO2<70%), n=27; and high group (HG, ScvO2>70%), n=23. Before transfusion 
ERO2 and lactate levels were significantly higher in the LG as compared to the HG. After 
transfusion Hb increased significantly in both groups. There were no significant changes in 
ScvO2 and ERO2 in the HG, while on the contrary in the LG ScvO2 and ERO2 improved 
significantly. Regarding other cardiorespiratory variables, there were variably significant 
changes in MAP, HR, CVP, SaO2, lactate but values remained in the physiologic range in 
both groups. 
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Before After Before After
Hb (g/L) 7.8(7.1- 9.2(8.0-9.9)* 7.7(7.1-8.1) 8.9(7.9-9.6)*
ScvO2 (%) 62(57-64) 70(66-72)* 77(75-80)# 79(76-82) 
SaO2 (%) 99(95-99) 100(99-100) 98(95-99) 98(97-99)
MAP (mmHg) 70(64-88) 80(70-90) 75(67-80) 78(71-91)*
HR (beat/min) 96(90-125) 87(74-113)* 100(88-110) 90(80-102)*
CVP (mmHg) 8(6-10) 10(9-11) 8(4-9) 9(5-12)*
Lactate (mmol/L) 1.7(0.9- 1.2(0.9-3.3) 1.0(0.8-1.2)# 0.7(0.5-1.1)*
ERO2 (%) 38(35-48) 27(20-29)* 21(16-24)# 20(15-22)
LG HG
Table 3 LG (ScvO2≤70%) vs. HG (ScvO2>70%)
 
*p <.05 Wilcoxon test; #p
 
<.05 Mann-Whitney test. 
 
 
 
1.3. Discussion 
 
The main finding of this retrospective study is that patients with low Hb but normal 
ScvO2 levels may have received unnecessary blood transfusion, as transfusion was not 
accompanied by any significant changes in ScvO2 and ERO2. 
The value of ScvO2 depends on hemoglobin, arterial oxygen saturation of hemoglobin, 
cardiac output and oxygen consumption as previously described. We found that arterial 
oxygen saturation of hemoglobin remained in the normal range. As far as the change of 
macro-hemodynamic parameters (mean arterial pressure, heart rate) indicate the change of 
cardiac output, it did not clinically significantly change either. 
As lactate levels differed significantly between the two groups before transfusion, 
oxygen consumption
 
may have been increased only in LG and not in HG. Moreover, for 
transfusion ScvO2 increased significantly only in LG, not in HG. Thus, blood transfusions in 
HG may be arguable. 
For the retrospective study design and the limitation of parameters measured, we 
decided to perform an animal experiment in order to test the current findings under controlled 
circumstances.  
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2. Changes of ScvO2 in isovolemic anemia – an animal experiment  
 
2.1. Materials and Methods 
 
The study protocol was approved by the local ethics committee at the University of 
Szeged, and the study was carried out in the research laboratory of the Institute of Surgical 
Research. 
 
Animals and Instrumentation.  
 
Vietnamese mini-pigs (n=13) weighing 24±3 kg underwent a 24-hr fast preoperatively 
but with water ad libitum. Anesthesia was induced with an intramuscular injection of a 
mixture of ketamine (20 mg/kg) and xylazine (2 mg/kg) and maintained with a continuous 
infusion of propofol (6 mg/kg/hr iv.). A tracheal tube was inserted and the animals’ lungs 
were ventilated mechanically. The tidal volume was set at 13±2 mL/kg, and the respiratory 
rate was adjusted to maintain the end-tidal carbon dioxide and the partial pressure of arterial 
carbon dioxide in the range of 35-45 mm Hg and the arterial pH between 7.35 and 7.45. The 
adequacy of the depth of anesthesia was assessed by monitoring the jaw tone. After the 
initiation of anesthesia, the right carotid artery and jugular vein and the right femoral artery 
and vein were dissected and catheterized. The animals underwent suprapubic urinary catheter 
placement and laparotomy for splenectomy. Splenectomy in swine haemorrhage models are 
performed because of the distensibility of the spleen and the resultant variation in the amounts 
of sequestered blood.29 The core temperature was maintained at 37±1 oC through use of an 
external warming device.  
For invasive hemodynamic monitoring, a transpulmonary thermodilution catheter 
(PiCCO, PULSION Medical Systems AG, Munich, Germany) was placed in the femoral 
artery and a pulmonary artery catheter (PV2057 VoLEF Catheter, PULSION Medical 
Systems AG, Munich, Germany) by pressure tracings via the femoral vein. The latter was also 
used to draw mixed venous blood gas samples. The femoral artery served as the site of arterial 
blood gas samples and the central venous line was used for central venous blood gas sampling 
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and for the injection of cold saline boluses for thermodilution measurements. During the 
experiment blood was drained from the catheter in the right carotid artery, which was also 
used to replace the blood loss with the same amount of colloid, in order to avoid a sudden 
increase in right ventricular preload.    
 
Experimental Protocol.  
 
The most important steps in the experiment are outlined in Figure 1. At baseline (T0) 
hemodynamic and blood gas parameters were recorded and heparin sulphate (200 IU/kg) was 
administered through the central venous line. Isovolemic anemia was achieved in five 
intervals (T1-T5). During each interval 10 % of the estimated total blood volume was 
withdrawn over a 5-10-minutes period. Hemodynamic parameters were recorded and the 
amount of blood drained off was immediately replaced by an equal volume of colloid 
(hydroxyethyl starch 130 kDa/0.4, 6%, Voluven, Fresenius, Germany). To achieve a steady 
state, the animals were allowed to rest for 10 minutes between intervals. At the end of each 
cycle, hemodynamic and blood gas parameters were measured. At the end of the experiment 
the animals were humanely euthanized. 
 
 
 
 
Hemodynamic Measurements.  
 
Cardiac output, global end-diastolic volume, extravascular lung water, stroke volume, 
stroke volume variation, index of left ventricular contractility, heart rate, and mean arterial 
pressure were measured by transpulmonary thermodilution and pulse contour analysis at 
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baseline and at the end of each interval. Detailed description of transpulmonary 
thermodilution and pulse contour analysis is provided elsewhere.29,30 All hemodynamic 
parameters were indexed for body surface area. The averages of three random measurements 
following 10 mL bolus injections of ice-cold 0.9 % saline were recorded. Continuous 
variables of invasive blood pressure measurements and pulse contour analysis, such as cardiac 
output, mean arterial pressure, heart rate, stroke volume, stroke volume variation and index of 
left ventricular contractility were measured and recorded at the end of each bleeding episode 
and at the same times as the other hemodynamic variables. The central venous pressure was 
monitored continuously and registered with a computerized data-acquisition 
system (SPELL Haemosys; Experimetria Ltd., Budapest, Hungary).  
Arterial, central venous and mixed venous blood gas samples (Cobas b 221, Roche 
Ltd, Basel, Switzerland) were drawn and analysed by cooximetry simultaneously at baseline 
and at the end of each cycle (Figure 1). 
  From these parameters oxygen delivery, oxygen consumption, oxygen extraction and 
the simplified oxygen extraction were calculated according to previously described standard 
formulae.  
 
Data Analysis and Statistics.  
 
Data are reported as median (interquartile ranges), unless indicated otherwise. To test 
for normal distribution, the Kolmogorov-Smirnov test was used. The changes in all 
parameters throughout the experiment were tested by repeated measures analysis of variance 
(ANOVA); and the number of degrees of freedom was adjusted to Greenhouse-Geisser 
epsilon when needed. For pairwise comparisons, Pearson’s correlation was used. To evaluate 
the performance of ScvO2 in the detection of altered oxygen extraction with a threshold of 
30% of VO2/DO2, receiver operating characteristics (ROC) curve analysis was performed, and 
sensitivity, specificity, and positive predictive (PPV) and negative predictive values (NPV) 
were also determined (Appendix B.). To model the linear relationship between VO2/DO2 and 
the possible indicator of altered oxygen extraction, linear regression model was used. Post-
hoc calculation showed a power of 86% with an effect of 25% increase in VO2/DO2, for a 
sample size of 13 and α=0.05. For statistical analysis SPSS version 18.0 for Windows (SPSS, 
Chicago, IL) was used and p< .05 was considered statistically significant. 
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2.2. Results 
 
Hemodynamic Effects of Isovolemic Anemia.  
All 13 animals survived the study. The blood loss was on average 150 ± 33 mL in each 
phase. Hemodynamic data are presented in Table 4. 
The bleeding caused a gradual decrease in hemoglobin level after each phase and by 
the end of the experiment it had fallen by 61% of the baseline value. The preload as indicated 
by global end-diastolic volume and central venous pressure values did not change 
significantly. Heart rate, index of left ventricular contractility and cardiac index were 
increased significantly after the first bleeding and remained so for the rest of the experiment. 
Mean arterial pressure decreased significantly from T2, but the median remained >70 mmHg 
throughout. Other macro-hemodynamic variables did not change significantly during the 
experiment. 
 
Table 4 Hemodynamic Effects of Isovolemic Anemia 
 T0 T1 T2 T3 T4 T5 
Hb (g/L) 125(113-134) 102(90-109)*# 79(73-93)*# 68(60-76)*# 59(53-67)*# 49(43-55)*# 
HR (beats/min) 125(91-135) 119(100-138)* 123(102-146)* 129(110-159) * 139(118-179) * 147(131-177)* 
MAP (mm Hg) 91(79-105) 89(79-101) 83(75-98)* 82(68-90)* 72(59-85)* 72(63-86)* 
CVP (mm Hg) 6(5-8) 8(5-9) 7(4-9) 7(5-9) 7(5-9) 7(3-10) 
CI (L/min/m2) 2.6(2.3-2.8) 3.3(2.7-3.6)*# 3.6(2.9-3.8)*# 3.6(3.3-4.1)* 3.5(3.2-4.0)* 3.9(3.6-4.1)* 
GEDI (mL/m2) 270(243-284) 271(245-320) 276(248-298) 274(236-305) 268(227-302) 261(232-298) 
ITBI (mL/m2) 335(307-352) 335(305-400) 343(303-373) 342(295-383) 334(282-375) 333(285-375) 
ELWI (mL/kg) 9(9-10) 10(10-10) 9(9-10) 10(9-10) 10(9-10) 10(9-11) 
SVI (mL/m2) 21(18-29) 26(23-31) 27(24-31) 28(25-31) 25(21-33) 28(22-31) 
SVV (%) 17(14-21) 15(12-21) 19(9-21) 15(11-20) 19(11-25) 14(11-27) 
dPmx (mm Hg/s) 540(485-790) 700(540-985)* 800(570-1075)* 810(540-1480)* 880(560-1360)* 975(562-1275)* 
Hb- Hemoglobin, HR- Heart rate, MAP- Mean arterial pressure, CVP- Central venous pressure, CI- Cardiac index, GEDI- Global end-diastolic volume index, 
ITBI- Intrathoracic blood volume index, ELWI- Extravascular lung water index, SVI- Stroke volume index, SVV- Stroke volume variation, dPmx- Index of left 
ventricular contractility. T0- Baseline measurement, T1-T5- Five intervals of bleeding. 
*p <.05 compared with T0; #p <.05 compared with previous; GLM repeated measures ANOVA 
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Effects on Oxygen Balance.  
Variables related to oxygen balance are listed in Table 5. 
 
Table 5 Effects of Isovolemic Anemia on Oxygen Balance 
 T0 T1 T2 T3 T4 T5 
SaO2 (%) 95(92-97) 96(94-97) 96(95-97) 96(95-97) 97(97-97) 97(97-97) 
DO2 (mL/min/m2) 431(362-474) 438(323-524) 378(302-412)*# 344(252-376)* 284(236-333)* 247(216-292)*# 
VO2 (mL/min/m2) 119(82-139) 130(77-151) 93(66-136) 113(67-141) 98(72-120) 105(70-120)  
VO2/DO2 (%) 29(18-33) 29(17-33) 29(18-32) 35(21-40)* 37(26-43)* 41(27-47)* 
ERO2 (%) 19(13-26) 19(14-24) 20(14-22) 21(16-28) 30(22-37)* 32(21-39)* 
SvO2 (%) 68(64-77) 67(64-77) 68(63-79) 64(58-76) 62(55-72)* 58(52-72)* 
ScvO2 (%) 76(69-83) 73(72(82) 77(75-83) 77(68-81) 68(61-76)* 66(60-76)* 
Lactate (mmol/L) 4.5(3.2-5.3) 4.2(3.0-5.1) 5.0(3.2-6.0) 4.1(2.9-6.0) 4.2(2.9-6.5) 4.0(3.0-6.4) 
pH 7.44(7.40-7.50) 7.43(7.40-7.50) 7.43(7.41-7.50) 7.43(7.39-7.49) 7.44(7.42-7.49) 7.44(7.40-7.47) 
PaO2 (mm Hg) 76(66-80) 75(72-80) 76(73-80) 77(72-82) 79(75-85) * 81(77-90) * 
PaCO2 (mm Hg)            39(35-44) 38(35-43) 37(34-45) 39(34-46) 37(34-42) 38(35-41) 
aHCO3 (mmol/L) 25(24-27) 24(24-26) 25(23-27) 25(23-27) 25(22-27) 25(21-25) 
aBE (mmol/L) 0.90(-0.05-2.50) 0.40(-0.85-2.25) 0.60(-0.9-2.45) 0.80(-0.45-3.15) 0.90(-1.45-2.35) 0.70(0.43-1.08) 
SaO2- Arterial oxygen saturation, DO2- Oxygen delivery, VO2- Oxygen consumption, VO2/DO2- Oxygen extraction ratio, ERO2- Simplified oxygen extraction 
ratio, SvO2- Mixed venous oxygen saturation, ScvO2- Central venous oxygen saturation, PaO2 – Arterial oxygen partial pressure, PaCO2 – Arterial carbon dioxide 
partial pressure, aHCO3 – Arterial bicarbonate,  aBE – Arterial base excess 
T0- Baseline measurement, T1-T5- Five intervals of bleeding. 
*p <.05 compared with T0; #p <.05 compared with previous; GLM repeated measures ANOVA 
 
 
Arterial oxygen saturation of hemoglobin remained in the normal range throughout the 
experiment. DO2 fell significantly from T2, VO2 at T4, VO2/DO2 increased significantly from 
T3, and exceeded the physiologic threshold of 30%. The change in ScvO2 displayed a similar 
pattern as VO2/DO2 and changed significantly and also fell below 70% only at T4. The other 
parameters did not change significantly. The pattern of changes of VO2/DO2 and ScvO2 over 
time is demonstrated in Figure 2. 
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We determined the association between VO2/DO2 and ScvO2, and found a strong, 
negative correlation (r=-.71, p<.001) (Figure 3). 
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ROC analysis revealed the same tendency as the correlation. With 30% taken as the 
physiologic threshold for VO2/DO2, the area under the curve (AUC), its standard error and 
that of the 95% confidence interval were >0.5 for ScvO2 (AUC=0.768 ± 0.056 [0.657-0.878] 
p<.001). It was also important to determine the best cut-off for ScvO2 to detect the significant 
increase in VO2/DO2, therefore, sensitivity, specificity, PPV and NPV for ScvO2 levels of 
70% and 75% were calculated. A ScvO2 level of 70% had better specificity and PPV, while a 
ScvO2 level of 75% had better sensitivity and NPV (Table 6). Furthermore, linear regression 
revealed a significant relationship between ScvO2 (r=-.71, r2=.50, p<.001) and VO2/DO2. 
 
 
Table 6 Performance of ScvO2 in Detecting VO2/DO2>30% 
 
ScvO2 < 70% ScvO2 < 75% 
Sensitivity (%) 45 68 
Specificity (%) 97 77 
PPV (%) 95 79 
NPV (%) 58 65 
ScvO2- Central venous oxygen saturation, VO2/DO2- Oxygen extraction ratio,  
PPV – positive predictive value, NPV – negatíve predictive value 
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2.3. Discussion 
 
Maintaining adequate tissue oxygenation by improving oxygen delivery is the rational 
for blood transfusion. Despite this fact, treatment of anemia with blood transfusion in the 
absence of acute bleeding is recommended at certain levels of hemoglobin, regardless of 
actual oxygen delivery and need, thus resulting in possible excess blood administration.8,9 In 
our study in isovolaemic anemia, we found that ScvO2 is a sensitive indicator of oxygen 
balance and may thus serve as a rational guide to therapy in this all too common problem. 
 
 
Oxygen balance and ScvO2.  
 
In certain clinical conditions, an ScvO2 value of ~70% has been used as a goal to 
therapeutic intervention in attempts at improving oxygen delivery.19,23,31,32 In one study in 
septic patients goal directed therapy according to ScvO2 values, saw an absolute 16% 
reduction in in-hospital mortality as compared to conventional therapy.19 Two recent studies 
have also demonstrated that a low ScvO2 predicts peri- and postoperative morbidity and 
complications in high-risk surgery.23,31 It may also serve as a useful tool to assist the weaning 
process in mechanically ventilated patients.32  
In our experiment, despite a continuous and significant drop in hemoglobin levels, the 
value of VO2/DO2 increased significantly only from T3, and exceeded the physiologic 
threshold of 30%. The change in ScvO2 displayed a similar pattern as VO2/DO2 and fell 
below 70% only at T4. If we translate that into clinical practice, the reduced hemoglobin 
concentrations could have indicated blood transfusion from T2, however, we found no 
evidence of impaired VO2/DO2 until the hemoglobin was well below the current 
recommended transfusion threshold. 
About two decades ago it was found during haemorrhage in animal and human 
experimental models that ScvO2 may be useful for the identification of patients with occult or 
ongoing clinically significant blood loss.33,34 In a prospective human interventional study it 
was found that in acute isovolaemic anemia of hemoglobin 50 g/L in conscious healthy 
resting humans did not produce evidence of inadequate systemic DO2 and oxygen imbalance 
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was accompanied by a significant drop in mixed venous saturation.35 These results were 
reinforced by a retrospective analysis of a prospective observational study in which ScvO2 
was found to be a good indicator of transfusion.36 Our results give further evidence that 
anemia-induced change in oxygen balance can be monitored by ScvO2. 
 
Hemodynamic effects of Isovolaemic Anemia.  
 
Our goal of maintaining isovolemia was achieved as parameters of preload and central 
blood volume, such as global end-diastolic volume and central venous pressure did not 
change throughout the experiment. A significant increase in cardiac index was found, due to 
increased heart rate, as stroke volume did not change significantly over time. This increase 
was in agreement with the hemodynamic changes of a recent study by Krantz et al. with a 
similar experimental setting, but with a different hypothesis.37 Myocardial contractility as 
indicated by the index of left ventricular contractility value also increased significantly, most 
likely in response to isovolemic anemia. Although we did not measure catecholamine levels, a 
theoretical explanation could be that the bleeding caused an enhanced stress response 
resulting in the observed positive inotropic effect.38,39  
 
Limitations of the study.  
 
One of the possible limitations of our study was that the length of the recovery time 
after splenectomy may not have been satisfactory, and therefore the levels of lactate were 
above the normal range, although they did not change significantly and the relevance of this is 
questionable. The steady-state periods may also have been relatively short, although, the same 
time intervals have been used previously.40 Further, the type of fluid replacement may be 
important, and we cannot exclude the possibility that the use of different types of colloid 
solutions would affect the results. Finally, these data were obtained in anesthetized animals, 
and may not be applicable to conscious animals. 
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CO2-gap 
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3. Changes of CO2-gap in isovolemic anemia – an animal experiment 
 
3.1. Materials and Methods 
 
The study protocol was approved by the local ethics committee at the University of 
Szeged and the study was carried out in the research laboratory of the Institute of Surgical 
Research. 
This experiment complements the previously described data on the relationship of 
ScvO2 and isovolemic anemia. The animals and instrumentation, the experimental protocol 
(Figure 1) and the hemodynamic measurements are detailed above.   
Arterial, central venous and mixed venous blood gas samples (Cobas b 221, Roche 
Ltd., Basel, Switzerland) were drawn and analyzed by cooximetry simultaneously at baseline 
and at the end of each cycle.  From these parameters the oxygen delivery (DO2), oxygen 
consumption (VO2), oxygen extraction ratio (VO2/DO2) and the simplified oxygen extraction 
ratio (ERO2) were calculated according to standard formulae: 
 
( )
( )( )
( )
2 2 2
2 2 2 2
2 2 2 2
DO SV R Hb SaO 0.003 PaO
VO CO CaO Hb 1.34 SvO 0.003 PvO
ERO SaO ScvO SaO
= ∗Η ∗ ∗1.34∗ + ∗  
 = ∗ − ∗ ∗ + ∗ 
= − / 
 
 
Central venous-to-arterial CO2-gap (cvCO2-gap), mixed venous-to-arterial CO2-gap 
(vCO2-gap) were also calculated from the arterial, central venous and mixed venous blood gas 
samples.  
These were calculated according to standard formulae: 
 
cv 2 cv 2 a 2
v 2 v 2 a 2
CO -gap P CO P CO
CO -gap P CO P CO
= −
= −
 
 
 
 
 
- 22 - 
Data Analysis and Statistics. 
 
Data are reported as median (interquartile ranges), unless indicated otherwise. For 
testing normal distribution the Kolmogorov-Smirnov test was used. Changes in all parameters 
throughout the experiment were tested by Friedman test and repeated measures analysis of 
variance (RM ANOVA), and the number of degrees of freedom was adjusted to Greenhouse-
Geisser epsilon when needed. For pairwise comparisons Pearson’s correlation was used. To 
evaluate the performance in detecting altered oxygen extraction of >30% (considered as the 
“physiological threshold”), receiver operating characteristics (ROC) curve analysis was 
performed. Post-hoc calculation showed a power of 86% with an effect of 25% increase in 
VO2/DO2, for a sample size of 13 and α=0.05. For statistical analysis SPSS version 20.0 for 
Windows (SPSS, Chicago, IL, USA) was used and p < .05 was considered statistically 
significant. 
 
 
3.2. Results 
 
 All 13 animals survived the study. The bleeding caused a gradual decrease in 
hemoglobin level after each phase and by the end of the experiment it had fallen by 61% of 
the baseline value. The hemodynamic parameters are summarized in Table 4.  The SaO2 
remained in the normal range throughout the experiment. DO2 fell significantly from T2, VO2 
at T4, VO2/DO2 increased significantly from T3, and exceeded the physiologic threshold of 
30% (Table 5). The change in ScvO2 displayed a similar pattern as VO2/DO2 and changed 
significantly and also fell below 70% only at T4. There was strong negative correlation 
between VO2/DO2 and ScvO2 (Figure 3). 
 
The CO2-gap was calculated for both, central venous (cvCO2-gap) and mixed venous 
blood (vCO2-gap). By T4 cvCO2-gap increased significantly, however vCO2-gap did not change 
(Table 7).  
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Table 7 Effects of Isovolaemic Anemia on Oxygen Balance 
 T0 T1 T2 T3 T4 T5 
cvCO2-gap (mmHg) 5.0(2.6-8.5) 6.0(3.1-7.0) 5.0(3.5-5.5) 5.4(4.4-7.0) 8.0(4.3-8.5)* 6.3(5.9-11.0)* 
vCO2-gap (mmHg) 5.5(4.0-9.0) 6.5(4.5-7.8) 6.5(5.1-7.0) 5.5(3.7-6.0) 5.4(5.0-8.0) 6.2(5.5-8.0) 
Lactate (mmol/L)  4.5 (3.2–5.3) 4.2 (3.0–5.1) 5.0 (3.2–6.0) 4.1 (2.9–6.0) 4.2 (2.9–6.5) 4.0 (3.0–6.4) 
vLactate (mmol/L) 4.6(3.7-5.3) 4.3(3.3-5.3) 4.4(3.1-5.4) 4.4(2.8-5.2) 4.4(3.0-5.2) 4.1(3.0-6.4) 
cvLactate (mmol/L) 4.5(3.5-5.5)§ 3.9(3.4-5.4)§ 4.2(3.3-6.3)§ 4.1(3.1-5.6)§ 3.9(2.9-5.7)§ 3.9(3.0-6.4)§ 
cvCO2-gap: central venous-to-arterial carbon dioxide difference; vCO2-gap: mixed venous-to-arterial carbon dioxide difference;  
* p< .05 as compared to baseline, § p< .05 significant difference between mixed venous and central venous blood with Friedman and Wilcoxon 
tests,  
 
 
The correlations of VO2/DO2 and ScvO2 were significant with cvCO2-gap, while there 
were only weak correlations with vCO2-gap (Figure 4). 
 
  Figure 4. Correlation between cvCO2-gap and VO2/DO2 and ScvO2;  vCO2-gap and VO2/DO2 and ScvO2. 
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ROC analysis revealed the same tendency as the correlation. With 30% taken as the 
physiologic threshold for VO2/DO2, the area under the curve (AUC), its standard error and 
that of the 95% confidence interval were >0.5 only for cvCO2-gap and ScvO2  (Table 8).  
 
Table 8 ROC analysis for determining VO2/DO2>30% 
Test Result Variable(s) Area Std. Error Sig. 95% CI 
cvCO2-gap ,769 ,078 ,007 ,617 ,921 
vCO2-gap ,553 ,097 ,598 ,363 ,742 
ScvO2 ,768 ,056 ,000 ,657 ,879 
SvO2 ,986 ,010 ,000 ,967 1,000 
Lactate ,517 ,078 ,867 ,363 ,670 
cvCO2-gap: central venous-to-arterial carbon dioxide difference; 
vCO2-gap: mixed venous-to-arterial carbon dioxide difference;  
ScvO2: central venous oxygen saturation;  
SvO2: mixed venous oxygen saturation;  
 
 Linear regression revealed a significant relationship between ScvO2 (r=0.71, r2=0.50, 
p<.001) and VO2/DO2. This relationship became significantly stronger when cvCO2-gap was 
added to ScvO2 (r=0.74, r2 =0.54, p<.015). According to the Pratt’s importance coefficient, 
ScvO2 was responsible for this increase in 63% and cvCO2-gap in 37%.  
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3.3. Discussion 
  
Our results in this isovolemic anemia animal model show that besides ScvO2, only 
central venous-to-arterial CO2-gap correlated well with changes in anemia caused increase in 
VO2/DO2. Furthermore, mixed venous blood driven indices, such as vCO2-gap failed to 
indicate changes in oxygen extraction. When oxygen extraction ratio started to increase (from 
T3) it was followed by a decrease of ScvO2 and an increase of cvCO2-gap, and both performed 
well in the ROC analysis, with the cvCO2-gap’s AUC being marginally better. In addition, in 
our experiment neither vCO2-gap nor lactate could detect the increase in VO2/DO2>30% as 
revealed by ROC analysis.   
An interesting finding of our experiment is that although isovolemia was maintained 
as indicated by the stable global end diastolic volume index values and in fact, cardiac output 
and stroke volume both increased, we observed a rise in cvCO2-gap. This observation 
seemingly contradicts previously published results to some extent. The occurrence of 
increased CO2-gap has fundamentally been explained by the CO2 stagnation phenomenon 25. 
This was based on the finding that there was inverse correlation between CO2-gap and cardiac 
index during non-septic and septic low flow states 25,26,41. Moreover, it was also found that the 
amount of CO2 produced is negligible when anaerobic respiration is present and CO2-gap 
therefore cannot serve as a marker of tissue hypoxia 41. The paramount study on this theory by 
Vallet et al. used an isolated hind limb model and reached hypoxia either by decreasing flow 
or decreasing arterial oxygen content 41. They found that occurrence of an increased CO2-gap 
during ischemia was related to decreased blood flow and impaired carbon dioxide washout; 
moreover, dysoxia per se was not sufficient to increase CO2-gap. However, the latter could 
also be due to Haldane’s effect. As the carbon dioxide dissociation curve is influenced by the 
saturation of hemoglobin with oxygen, the lower the saturation of hemoglobin with oxygen, 
the higher the saturation of hemoglobin with carbon dioxide for a given carbon dioxide partial 
pressure 42.  In our experiment arterial oxygen saturation and PaO2 remained in the normal 
range and did not change over time, hence the CO2 dissociation curve was not influenced by 
low saturation of hemoglobin with oxygen.  
 Nevertheless, anemia resulted in increased VO2/DO2 above the baseline and also 
above the physiological 30% after the 3rd bleeding event, which was followed by the 
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significant decrease of SvO2 and ScvO2. (It is important to note that there is mathematical 
coupling between VO2 and SvO2, this is not the case with ScvO2). The most interesting 
finding of the current study is the increase of cvCO2-gap during the last two stages of the 
experiment, without any change in the vCO2-gap. One of the possible reasons for this 
difference is that due to isovolemia cardiac output was maintained to avoid low flow in the 
systemic circulation, which is also reinforced by the unchanged lactate levels. Therefore when 
CO2 was measured in the mixed venous blood it was unchanged and within the normal range 
almost throughout. As central venous blood driven variables mostly reflect blood flow and 
metabolism of the brain 14, our hypothesis is that anemia reached such a degree by T4 that it 
caused tissue hypoxia and consecutive anaerobic respiration with CO2 production. However, 
due to the low hemoglobin levels the Haldane effect could not take effect, hence there was a 
significant increase in central venous pCO2. But these changes in the brain did not have 
significant effects on the systemic level, to be picked up in mixed venous blood. As anemia 
has greater influence on arterial oxygenation than hypoxemia 43, this might explain the 
observed increase in cvCO2-gap. We also measured mixed venous and central venous lactate 
levels and found that central venous lactate was significantly lower than in the mixed venous 
blood, which might give further proof to this hypothesis 44,45. In a previous animal experiment 
by Hare et al, it was found that hemodilutional isovolemic anemia led to cerebral hypoxia, 
and they also reported a gradual increase in the jugular venous pCO2 with a CO2-gap of 2.9 to 
7.8 mmHg (mean) 60 minutes after hemodilution in the traumatic brain injured animals 46. 
This finding was not discussed in the article, as the authors mainly focused on oxygenation, 
nevertheless this is in accord with our results and gives some support to our hypothesis. 
 There is increasing evidence that untreated anemia can be associated with a worse 
outcome and increased mortality, while transfusion may cause various infectious and non-
infectious adverse effects 11,13.
 cvCO2-gap may be an additional quantitative parameter, beyond 
Hb and ScvO2, that would give information on anemia related altered oxygen extraction and 
hence the need for blood administration. cvCO2-gap is a choice of plausible alternatives as it 
can be easily obtained via the central venous and arterial catheters already in situ in most 
critically ill patients and no additional invasive device is needed; moreover we found that 
mixed venous blood driven indices failed to indicate changes in oxygen extraction.  
 There are several limitations of our study. As the experiment was not designed to 
measure the effects of isovolemic anemia specifically on the brain, our hypothesis cannot be 
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supported by specific measurements, such as regional cerebral blood flow, cerebral tissue 
oxygen and carbon dioxide tension. Furthermore, splenectomy and the length of the 
preparation of the animals may have been too long, which resulted in increased levels of 
lactate from baseline to the end of the experiment. The steady-state periods may also have 
been relatively short, although, the same time intervals have been used previously 40. Another 
concern might be the type of fluid replacement, as one cannot exclude the possibility that the 
use of different types of colloid or crystalloid solutions would affect these results.  
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4. ScvO2 and CO2-gap in moderate hypovolemia – animal experiment 
 
4.1. Materials and Methods 
 
The study protocol was approved by the local Ethics Committee and the Institutional 
Animal Care and Use Committee at the University of Szeged and the study was conducted in 
the research laboratory of the Institute of Surgical Research in a manner that does not inflict 
unnecessary pain or discomfort upon the animal. 
 
Animals and Instrumentation.  
 
Vietnamese mini-pigs (n=15) weighing 28±4 kg underwent a 24-hr fast preoperatively 
but with free access to water. Anesthesia was induced by intramuscular injection of a mixture 
of ketamine (20 mg/kg) and xylazine (2 mg/kg) and maintained with a continuous infusion of 
propofol (6 mg/kg/hr iv.), while analgesia was maintained with nalbuphine (0.1 mg/kg). A 
tracheal tube was inserted and the animals’ lungs were ventilated mechanically. The tidal 
volume was set at 10 mL/kg, and the respiratory rate was adjusted to maintain the end-tidal 
carbon dioxide and partial pressure of arterial carbon dioxide in the range of 35-45 mmHg 
and the arterial pH between 7.35 and 7.45. The adequacy of the depth of anesthesia was 
assessed by monitoring the jaw tone. After induction of anesthesia, the right jugular vein and 
the right femoral artery and vein were dissected and catheterized. Tonometric probes and 
catheters were placed simultaneously into the stomach and the small bowel.  A suprapubic 
urinary catheter was also inserted to monitor urine output. Animals were kept warm (35±1oC) 
by an external warming device.  
For invasive hemodynamic monitoring, a transpulmonary thermodilution catheter 
(PiCCO, PULSION Medical Systems SE, Munich, Germany) was placed in the femoral artery 
and a pulmonary artery catheter (PV2057 VoLEF Catheter, PULSION Medical Systems SE, 
Munich, Germany) was placed in the femoral vein. The latter was also used to draw mixed 
venous blood gas samples with which the oxygen consumption (VO2) was calculated. The 
femoral artery served as the site for arterial blood gas sampling and the central venous line 
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was used for taking central venous blood gas samples and for the injection of cold saline 
boluses for the thermodilution measurements.  
For continuous noninvasive visualization of the microcirculation in the sublingual 
region an intravital orthogonal polarization spectral (OPS) imaging technique (Cytoscan A/R, 
Cytometrics, Philadelphia, PA, USA) was used.16,47 A 10x objective was introduced onto the 
sublingual serosa, and microscopic images were recorded with an S-VHS video recorder 
(Panasonic AG-TL 700, Osaka, Japan). 
For the tonometry special probes (Tonosoft Medical –Technical and R&G Ltd.) were 
used and monitoring was performed with a Sidestream Microcap Handheld Capnograph 
(Oridion Medical Ltd, Jerusalem, Israel) instrument.48 
To assess further biochemical changes in the microcirculation, plasma big-endothelin-
1 (BigET) levels were determined. BigET is a 38 amino acid containing protein, the precursor 
of endothelin-1, which becomes elevated in tissue hypoxia.49, 50 
 
Hemodynamic Measurements.  
 
Cardiac output (CO), global end-diastolic volume index (GEDI), stroke volume (SV), 
heart rate (HR), and mean arterial pressure (MAP) were measured by transpulmonary 
thermodilution and pulse contour analysis at baseline and at the end of each interval. Detailed 
description of transpulmonary thermodilution and pulse contour analysis is provided 
elsewhere.29,30 All hemodynamic parameters were indexed for body surface area or 
bodyweight. The average of three measurements following 10 mL bolus injections of ice-cold 
0.9% saline was recorded. Central venous pressure (CVP) was monitored continuously and 
registered with a computerized data-acquisition system (SPELL Haemosys; Experimetria 
Ltd., Budapest, Hungary). 
Arterial, central venous and mixed venous blood gas samples (Cobas b 221, Roche 
Ltd, Basel, Switzerland) were drawn and analyzed by cooximetry simultaneously at baseline 
and at the end of each cycle. 
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Monitoring the Microcirculation. 
   
Microcirculatory evaluation of the sublingual region was performed off-line by frame-
to-frame analysis of the videotaped images. Capillary red blood cell velocity (RBCV) and 
capillary perfusion rate (CPR) were determined in three separate fields using a computer-
assisted image analysis system (IVM Pictron, Budapest, Hungary). All OPS-measurements 
were performed by one investigator.  
Gastric and small bowel changes in partial pressure of carbon dioxide (∆PCO2) were 
calculated by subtracting tonometric PCO2 from arterial PCO2 (gastric-arterial: Ga-PCO2; 
bowel-arterial: Ba-PCO2).48 
For measurements of BigET, blood samples of 2 ml were drawn from the jugular vein 
into chilled polypropylene tubes containing EDTA (1 mg/mL). The samples were centrifuged 
at 1200g for 10 min at 4°C. The plasma samples were then collected and stored at -70°C until 
assay. 
 
Experimental Protocol.  
 
At baseline (T0) hemodynamic, blood gas and microcirculatory parameters were 
recorded (Figure 5). Hypovolemia was induced via a bolus followed by a continuous infusion 
of furosemide (5 mg/kg and 5 mg/kg/2h, respectively) in a group of 10 animals – 
hypovolemic group (HG). After the administration of bolus furosemide measurements were 
recorded in five stages with 20 minutes interval between each measurement (T1-T5). When the 
preload parameter (GEDI) decreased by >20% its baseline value, OPS imaging and BigET 
sampling were performed, which were repeated only at the end of the experiment (Figure 5). 
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Bolus: 5 mg/kg furosemide iv. 
 
 T0           T1                      T2                 T3                      T4                    T5       
20 min 
Continuous: 5 mg/kg/~120 min furosemide iv. 
Figure 5. Schematic diagram illustrating the experimental protocol. 
Measurements we performed at baseline (T0) and then in every 20 minutes (T1-5); symbols indicate hemodynamic/blood gas 
( ) and microcirculatory ( ) measurements. 
 
There were 5 anaesthetised, ventilated animals in the sham group (SG), who did not 
receive any furosemide, but maintenance infusion of lactated Ringer (4mL/kg/h) and 
hemodynamic, microcirculatory and blood gas parameters were recorded in the same fashion 
as described previously. At the end of the experiment all animals were humanely euthanized.
  
Data Analysis and Statistics. 
 
Data are reported as means ± standard deviations unless indicated otherwise. For 
testing normal distribution the Kolmogorov-Smirnov test was used. Changes in all parameters 
throughout the experiment were tested by repeated measures analysis of variance (RM 
ANOVA); and the number of degrees of freedom was adjusted to Greenhouse-Geisser epsilon 
when needed. Mann-Whitney U-test with Bonferroni correction was used for between-groups 
analysis. For pairwise comparisons Pearson’s correlation was used. To evaluate the 
performance of ScvO2, CO2-gap and microcirculatory parameters in detecting altered oxygen 
extraction with a threshold of 30%, receiver operating characteristics (ROC) curve analysis 
was performed, and sensitivity, specificity, positive predictive (PPV) and negative predictive 
values (NPV) were also determined. Post-hoc calculation showed a power of 83% with an 
effect of 36% decrease in GEDI
 
for a sample size of 10 and α=0.05. For statistical analysis 
SPSS version 18.0 for Windows (SPSS, Chicago, IL) was used and p<.05 was considered 
statistically significant. 
- 32 - 
4.2. Results 
 
Hemodynamic Effects of Hypovolemia. 
  
Urine output in the hypovolemic group following the bolus and the onset of infusion 
was 176±160 mL at T1, which increased to 647±231 mL at T5. In contrast, in the sham group, 
urine output was 74±74 mL at T1 and had increased to 325±175 mL by T5. All other 
hemodynamic data are summarized in Table 9. Preload, as indicated by GEDI, decreased 
significantly after each phase in the hypovolemic group compared to baseline and dropped by 
36% of its baseline value by the end of the experiment. The change of the other macro-
hemodynamic variables followed a similar pattern. When comparing the sham versus 
hypovolemic animals, variables differed between the two groups from T1, but significant 
differences over time continued only for GEDI, CVP and SVI. In the sham group there were 
no significant changes over time throughout the experiment. 
 
Table 9 Hemodynamic Changes 
  T0 T1 T2 T3 T4 T5 
GEDI mL/m2) 
HG 
SG 
349±51 
350±26 
293±53*‡# 
387±43 
257±47*‡# 
360±22 
246±53*# 
365±76 
233±42*# 
356±51 
223±31*# 
349±46 
CVP (mmHg) 
HG 
SG 
7±4 
8±1 
4±3*‡# 
7±1 
4±3*# 
7±1 
4±3*‡# 
7±2 
3±3*# 
7±1 
4±3*# 
7±2 
MAP (mmHg) 
HG 
SG 
121±15 
120±13 
107±17*‡ 
121±14 
94±19*‡ 
117±15 
86±15*‡ 
113±16 
85±15* 
121±24 
83±17* 
111±25 
HR (1/beats) 
HG 
SG 
78±14 
74±12 
83±15*‡ 
75±12 
93±17* 
74±9 
102±19* 
78±10 
130±28*‡ 
83±16 
142±28*‡# 
80±9 
CI (L/min/m2)  
HG 
SG 
2.30±0.35 
2.38±0.50 
1.78±0.31*‡ 
2.65±0.65 
1.54±0.32*‡ 
2.42±0.48 
1.46±0.35*‡ 
2.38±0.76 
1.52±0.41* 
2.32±0.50 
1.58±0.36* 
2.27±0.27 
SVI (mL/m2) 
HG 
SG 
29±5 
33±4 
19±2*‡# 
34±6 
15±4*# 
33±3 
14±4*# 
32±6 
12±4*# 
31±8 
12±3*# 
28±5 
GEDI- Global end-diastolic volume index, CVP- Central venous pressure, MAP- Mean arterial pressure, HR- Heart rate,  
CI- Cardiac index, SVI- Stroke volume index. 
T0- Baseline measurement, T1-T5- Five intervals. 
*p< .05 as compared to T1; ‡p< .05 as compared to the previous value; RM ANOVA;  
#p< .05 HG vs SG; Mann-Whitney U-test with Bonferroni correction 
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Effects on Oxygen Balance. 
 
Variables relating to oxygen balance are listed in Table 10. In the hypovolemic group 
DO2 fell significantly from T1 and remained so for the rest of the experiment. The VO2/DO2 
increased significantly over 30% from T1, while ScvO2 and CO2-gap followed this change 
only after T2. Lactate changed significantly from T3. There were no significant changes in the 
sham group throughout the experiment.  
 
Table 10 Changes of Oxygen Balance 
  T0 T1 T2 T3 T4 T5 
SaO2  
(%) 
HG 
SG 
94±6 
95±5 
95±5 
94±8 
95±2 
96±5 
96±2 
94±8 
94±3 
95±5 
94±2 
94±7 
Hb  
(g/L) 
HG 
SG 
122±9 
119±10 
129±13 
115±9 
132±7* 
110±6 
134±7*‡ 
108±11 
137±7*‡ 
111±9 
138±8* 
102±10 
DO2I  
(mL/min/m2) 
HG 
SG 
361±39 
365±78 
302±52*‡ 
396±88 
268±47*‡ 
346±73 
258±55* 
337±67 
269±65* 
324±55 
284±55* 
298±36 
VO2/DO2  
(%) 
HG 
SG 
28±5 
25±4 
31±6*‡ 
25±6 
34±7*‡ 
26±7 
39±9*‡ 
29±5 
41±9* 
27±6 
40±10* 
30±7 
ScvO2  
(%) 
HG 
SG 
74±10 
77±8 
71±10 
76±10 
67±11*‡ 
76±9 
64±14* 
75±11 
59±13*‡ 
73±14 
57±14* 
73±12 
CO2-gap  
(mmHg) 
HG 
SG 
4.3±2.3 
4.1±2.4 
7.5±3.3 
3.5±1.9 
7.1±2.6* 
4.5±1.3 
8.3±2.8* 
3.9±2.9 
7.3±2.9* 
4.6±1.9 
10.1±5.5*# 
4.4±1.9 
Lactate  
(mmol/L) 
HG 
SG 
3.8±1.4 
3.8±0.9 
3.9±1.3 
3.9±1.2 
4.3±0.9 
4.2±1.8 
4.7±0.9*‡ 
4.6±2.1 
5.1±1.2*‡ 
4.7±2.7 
5.3±1.5* 
4.9±3.2 
VO2I  
(mL/min/m2) 
HG 
SG 
98±11 
88±16 
93±16 
96±6 
88±9 
85±12 
96±7‡ 
96±8 
104±10‡ 
85±12 
109±16 
88±14 
SaO2- Arterial oxygen saturation, Hb- Hemoglobin, DO2- Oxygen delivery, VO2/DO2- Oxygen extraction ratio, ScvO2- Central 
venous oxygen saturation, CO2-gap- venous-to-arterial carbon dioxide difference, VO2- Oxygen consumption.  
T0- Baseline measurement, T1-T5- Five intervals.  
*p< .05 as compared to T1; ‡p< .05 as compared to the previous value; RM ANOVA;  
#p< .05 HG vs SG; Mann-Whitney U-test with Bonferroni correction 
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In the hypovolemic group there were significant correlations between VO2/DO2 and 
ScvO2, and CO2-gap (Figure 6A and 6B, respectively). Lactate also showed a significant, but 
weak correlation with VO2/DO2 (r= .38, r2= .14; p <.05).  
 
 
 
Figure 6A. Correlation between VO2/DO2 and ScvO2. 
  
Figure 6B. Correlation between VO2/DO2 and CO2-gap. 
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With Receiver Operator Characteristic (ROC) curves for ScvO2, CO2-gap and lactate 
to detect a VO2/DO2>30%, the area under the curves (AUC) was significant for ScvO2, CO2-
gap, (AUC±SE=0.887±0.046; 0.783±0.062; p<.05, respectively), while lactate did not reach 
statistical significance.  
The cut-off values to give the best sensitivity and specificity for ScvO2 and CO2-gap 
were: 73% and 6.5 mmHg, respectively. Sensitivity, specificity, positive predictive and 
negative predictive values for ScvO2 and CO2-gap are summarized in Table 11. Taking ScvO2 
and CO2-gap values together to predict a VO2/DO2>30% the false positive and false negative 
values were reduced.  
 
Table 11 Complemetation of ScvO2 with CO2-gap. 
 Sensitivity(%) Specificity(%) PPV(%) NPV(%) 
ScvO2 ≤ 73 % 78 83 91 63 
CO2-gap > 6 mm Hg 71 72 85 52 
ScvO2 + CO2-gap 
(≤73%) (>6 mm Hg) 
58 100 100 72 
ScvO2- Central venous oxygen saturation, CO2-gap- venous-to-arterial carbon dioxide difference,  
PPV- positive redictive value, NPV- Negative predictive value 
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Effects on Microcirculation. 
  
Variables relating to microcirculation are listed in Table 12.  
 
Table 12 Changes in Microcirculation. 
  T0 T1 T2 T3 T4 T5 
Ba-PCO2  
(mmHg) 
HG 
SG 
24±8 
19±5 
35±16*‡ 
22±9 
35±17 
20±6 
36±13* 
22±11 
33±13* 
22±10 
37±16* 
20±8 
Ga-PCO2  
(mmHg) 
HG 
SG 
40±12 
36±22 
43±14 
37±24 
42±14 
34±21 
39±14 
32±21 
36±10 
34±20 
37±11 
32±18 
CPR  
(%) 
HG 
SG 
82±15 
91±50 
- 53±11*‡# 
81±80 
- - 45±16*‡# 
83±70 
RBCV  
(µm/s) 
HG 
SG 
887±141 
1054±141 
- 509±120*‡# 
848±194 
- - 463±209*# 
963±51 
BigET  
(fmol/mL) 
HG 
SG 
1.44±0.53 
1.36±0.93 
- 1.97±0.84*‡ 
1.49±1.27 
- - 2.29±0.89*# 
0.98±0.92* 
Ba-pCO2- Small bowel-to-arterial carbon dioxide difference, Ga-pCO2- Gastric-to-arterial carbon dioxide difference,  
CPR – Capillary perfusion rate, RBCV- Red blood cell velocity, BigET- Big-endothelin.  
T0- Baseline measurement, T1-T5- Five intervals.  
*p< .05 as compared to T1, ‡p< .05 as compared to the previous value, GLM repeated measures ANOVA;  
#p< .05 HG vs SG, Mann-Whitney U-test with Bonferroni correction 
 
In the hypovolemic group tonometry increased significantly only when measured in 
the intestines. Capillary perfusion rate and red blood cell velocity gradually and significantly 
decreased over time. This change was accompanied by a significant increase in BigET levels. 
In contrast, the sham group BigET decreased significantly by T5, while the other parameters 
remained unchanged. There was a significant difference in capillary perfusion rate, red blood 
cell velocity and BigET between the two groups. (Figure 7A and 7B, respectively). 
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          Figure 7A. Significant decrease of capillary perfusion rate.   Figure 7B. Significant decrease of red blood cell velocity. 
          
 
    
 
 
The ROC curves for predicting VO2/DO2>30% proved to be significant for capillary 
perfusion rate and red blood cell velocity in the hypovolemic group. The area under the curve 
did not differ significantly between these two parameters (AUC±SE=0.848±0.084; 
0.848±0.092; p<.05, respectively). 
 
The correlation between ScvO2 and the microcirculatory parameters proved to be 
significant apart from Ga-PCO2 (ScvO2 - Ba-PCO2, - CPR, - RBCV, - BigET: r=-.38, r2=.15; 
r=.49, r2=.24; r=.40, r2=.16; r=-.47, r2= .23; p<.05, respectively). CO2-gap showed significant 
correlations with Ba-PCO2 and CPR (r=.48, r2=.23; r=-.51, r2=.26; p<.05, respectively). 
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4.3. Discussion 
 
The main finding of our study is that it provides further evidence that low or 
decreasing ScvO2, as well as high or increasing CO2-gap can reflect changes and may be 
complementary in global oxygen balance and altered microcirculatory blood flow in 
hypovolemia. 
 
Hemodynamic changes. 
  
Our goal of achieving hypovolemia was reached as global end diastolic index, central 
venous pressure and stroke volume decreased significantly throughout the experiment, which 
resulted in a significant drop in cardiac index in the hypovolemic group. This decrease was 
notable until T3. Due to this change VO2/DO2 increased significantly from T1.  
 
CO2-gap and ScvO2 in Hypovolemia. 
 
Up until now, there has been consensus neither on the most accurate hemodynamic 
marker of hypovolemia, nor on the end-points for optimal fluid therapy.15,51,52 Many recent 
studies have suggested that fluid therapy should be based on dynamic (such as: cardiac 
output, pulse pressure variation, stroke volume variation) rather than static hemodynamic 
variables (such as: CVP, pulmonary artery occlusion pressure),  because they are better 
predictors of fluid responsiveness in ICU patients. However, pulse pressure variation and 
stroke volume variation are limited to patients who are fully ventilated and have no 
arrhythmias.53,54 Although it is not strictly a hemodynamic variable but in certain clinical 
conditions an ScvO2 value of ~70% has been used as a therapeutic end-point to improve 
oxygen delivery.19,23,31-32 In a recent study it was found that change in ScvO2 is a reliable 
parameter to define fluid responsiveness at the bedside in critically ill patients.21 Similar 
results have been reported in two other studies demonstrating a close relationship between 
ScvO2 and cardiac index.22,55  However, one has to bear in mind that fluid resuscitation 
reduces hemoglobin levels, which may result in no change or decrease in ScvO2 therefore, the 
above may only hold true for hypovolemic patients with low ScvO2. 
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In our experiment the change in VO2/DO2, which increased significantly from T1 was 
accompanied by a fall in ScvO2, which is in accord with previous findings. The change in 
VO2/DO2 was also accompanied by an increase in CO2-gap from T2. There is some evidence 
that CO2-gap increases in certain low flow states.25,27 The pathophysiology of increased CO2-
gap may be due to the CO2 stagnation phenomenon. When cardiac output decreases, blood 
flow is slow and the washout is impaired, therefore more CO2 is accumulated in the tissues 
and as CO2 diffuses easily and quickly the CO2-gap increases.41  
ScvO2 showed very good sensitivity and specificity with a threshold of 73% for 
determining VO2/DO2>30%, which was further improved when CO2-gap>6.5 mmHg was 
added, leading to less false negative and false positive results. The ScvO2 and CO2-gap 
showed a significant and strong negative correlation. It is also important to note that lactate 
showed a significant but substantially weaker correlation to VO2/DO2 as compared to ScvO2 
or CO2-gap. This highlights the limitation of lactate levels as therapeutic endpoint for 
resuscitation. This finding is in accordance with previously published data showing the 
limitation of lactate levels as therapeutic endpoint for resuscitation.56  
 In cases when due to microcirculatory and/or mitochondrial defects oxygen uptake is 
insufficient, ScvO2 may be elevated (i.e.: false negative). Previous studies have suggested that 
under such circumstances the increased value of CO2-gap (>5mmHg), may help the clinician 
in detecting inadequate DO2 to tissues.25,26-27 Our results lend further support to this theory. 
Furthermore, adding the CO2-gap to ScvO2 for identifying VO2/DO2>30%, there was an 
improvement in specificity, positive predictive and negative predictive values.   
We are not aware of any studies that have tailored hemodynamic support based on or 
supported by changes in CO2-gap, therefore its clinical relevance remains unclear. However, 
our data clearly shows, and to our knowledge this is the first experiment to show that an 
altered VO2/DO2 caused by hypovolemia is reflected by an increase in CO2-gap. Therefore its 
value may be an important alarm signal for the clinician and would help decision making at 
the bedside, especially when considering a fluid challenge or where commencing advanced 
hemodynamic monitoring are concerned. 
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Microcirculation. 
 
 In any shock like states the microcirculation plays a vital role, as the most devastating 
effects of oxygen debt occur here in the cells.16,55 It has been demonstrated that 
microcirculatory disturbances can occur not only in cases of severe hypovolemic shock, but 
also in cases of a moderate hypovolemia without severe hypotension in human patients.57 
Recently, Bartels et al. evaluated the alteration of the sublingual microcirculation in response 
to controlled, central hypovolemia using sidestream dark field imaging in human subjects 
with intact autoregulation. They confirmed that despite adequate compensation of 
hypovolemia it can still be associated with decreased microcirculatory response, consequently 
with decreased oxygen delivery to the tissues.58  
In a prospective observational study in patients with septic shock it was found that the 
capillary perfusion rate was different in survivors (in whom it was increased) as compared to 
non-survivors. Moreover, it was the only factor to differentiate survivors and patients dying of 
multiple system organ failure after the shock had resolved.16 In accordance with these results 
we saw a gradual and significant decrease in both capillary perfusion rate and red blood cell 
velocity over time. There was also a very good area under curve when defining 
VO2/DO2>30%, and good correlation with ScvO2 and CO2-gap. All these changes were 
observed only in the hypovolemic, but not in the sham group. 
According to the microcirculatory parameters measured in this experiment, the 
inflicted hypovolemia resulted in significant changes to the microcirculation. Tonometry 
showed a significant increase in Ba-PCO2 due to hypovolemia, indicating decreased blood 
flow in the intestines. This is in accordance with previously published reports.59 In contrast, 
there was no significant change in the Ga-PCO2. Regarding the importance and the value of 
gastric mucosal pH is controversial and its routine use has declined in intensive care over the 
last decades.60-62 The difference between Ga-PCO2 and Ba-PCO2 is an interesting observation 
and also difficult to explain. However monitoring both has already been suggested, in order to 
give a small additional value in the diagnosis of possible mismatch in splanchnic 
perfusion.63,64 There was also a significant correlation between Ba-PCO2 both with ScvO2 and 
CO2-gap. 
- 41 - 
Little is known about BigET, but there is some evidence that ET-1 reflects tissue 
hypoxia.49,65 However, in contrast to the insignificant change in BigET found in healthy 
volunteers suffering from acute hypoxia, our results showed a significant difference of BigET 
levels between the hypovolemic and the sham groups, which indicates that there is an effect 
of hypovolemia induced tissue hypoxia on BigET levels.66  
 
 
 
Limitations of the study. 
 
One of the possible limitations of our study is the long preparation period which might 
have resulted in the slightly elevated lactate levels, although this was observed in both groups. 
Its clinical impact may be limited as a decreased ScvO2 and elevated CO2-gap may be 
influenced by several factors other than hypovolemia, including heart failure, severe 
sepsis/septic shock, multiple trauma etc., thus these results can only be applied when these 
conditions are unlikely to be present, for example in postoperative critical care. Furthermore, 
these data were obtained in anesthetized animals, and may not be the same in conscious 
human subjects. Finally, as there are no gold standards for hypovolemic animal experiments, 
one cannot exclude that the choice of furosemide-caused hypovolemia may not be the most 
appropriate model. The disadvantage of this model is that it does not replicate real life clinical 
diseases. Traumatic hypovolemia and hypovolemia associated with sepsis are associated with 
profound microcirculatory changes which become superimposed on the changes following 
hypovolemia. This is particularly important in patients with sepsis, where ScvO2 is known to 
be a poor marker of tissue oxygenation. Indeed, in patients with sepsis, a high rather than a 
low ScvO2 is predictive of mortality. 
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Conclusions 
 
 
Ά In nearly 50% of patients transfusion was not followed by an increase in central 
venous oxygen saturation, which implies unnecessary transfusions and highlights the 
need for additional physiological transfusion triggers.  
 
Ά Central venous oxygen saturation reflects changes of oxygen extraction in isovolaemic 
anemia. Furthermore, compared to hemoglobin concentration alone, changes in 
central venous oxygen saturation better identify the point when compensatory 
mechanisms fail and oxygen delivery begins to decline.  
 
Ά Central venous-to-arterial CO2 difference may increase due to altered oxygen 
extraction caused by anemia, and may support the change in central venous oxygen 
saturation.  
 
Ά In addition to central venous oxygen saturation, central venous-to-arterial CO2 
difference may also be used as a simple and valuable indicator of hypovolemia.  
 
 
In diagnosing inadequate oxygen delivery due to anemia related decreased arterial oxygen 
content or hypovolemia related low cardiac output the values of central venous oxygen 
saturation and central venous-to-arterial carbon dioxide difference may be favorable.
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Central venous oxygen saturation is a good indicator of
altered oxygen balance in isovolemic anemia
S. Kocsi1, G. Demeter1, J. Fogas1, D. Érces2, J. Kaszaki2 and Z. Molnár1
1Department of Anaesthesiology and Intensive Therapy, Faculty of Medicine, University of Szeged, Szeged, Hungary, and 2Institute of Surgical
Research, Faculty of Medicine, University of Szeged, Szeged, Hungary
Background: Red blood cell transfusion is done primarily as a
means to improve oxygen delivery (DO2). Current transfusion
guidelines are based solely on hemoglobin levels, regardless of
actual DO2 need. As central venous oxygen saturation (ScvO2)
may reflect imbalances in DO2 and consumption (VO2) the aim
of this study was to investigate the value of ScvO2 as an indicator
of oxygen balance in isovolemic anemia.
Methods: After splenectomy, anesthetized Vietnamese mini
pigs (n = 13, weight range: 18–30 kg) underwent controlled
bleeding in five stages (T0–T5). During each stage approximately
10% of the estimated starting total blood volume was removed
and immediately replaced with an equal volume of colloid.
Hemodynamic measurements and blood gas analysis were then
performed.
Results: Each stage of bleeding resulted in a significant fall in
hemoglobin, T0: 125 (113–134) to T5: 49 (43–55) g/l [T0: 7.7 (6.9–
8.2) to T5: 3.0 (2.6–3.4) mmol/l]. The O2-extraction (VO2/DO2)
increased significantly only from T3: 35 (21–40) %, P < 0.05. The
change of ScvO2 showed a similar pattern and dropped below
the physiological threshold of 70% at T4: 68 (61–76) %. At this
point, hemoglobin was below the recommended transfusion
trigger value, 59 (53–67) g/l [3.6 (3.3–4.1) mmol/l]. There was a
strong significant association between ScvO2 (< 70%) and VO2/
DO2 (> 30%): r = -0.71, r2 = 0.50, P < 0.001.
Conclusion: The results of this study show that ScvO2 reflects
changes of VO2/DO2 in isovolemic anemia better than Hb alone,
therefore it may be used as an additional indicator of blood
transfusion in clinical practice.
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The adequacy of tissue oxygenation is deter-mined by the balance between oxygen delivery
(DO2) and consumption (VO2).1 In the critically ill
there is often an imbalance between the two arms:
DO2 may be too low, frequently to the accompani-
ment of an increased VO2. After a critical threshold,
severe oxygen debt and shock may occur.2 One of
the most common causes of inadequate DO2 in the
intensive care unit is anemia requiring red blood
cell transfusions.3 Although the prevalence of
anemia among critically ill patients could be as high
as 95% by day 3, the transfusion trigger, i.e. the
indication and timing of the necessity of blood
transfusion, is still uncertain, and the detection of
altered oxygen extraction caused by anemia is there-
fore of great clinical importance.4,5
A number of guidelines are of help in transfusion
practice, but the criteria for the optimal manage-
ment of anemia are not clearly defined. In most
guidelines the transfusion trigger is a certain level
of hemoglobin (Hb), usually 70–100 g/l (4.3–
6.1 mmol/l).6,7 It was recently suggested that Hb
level should not be the only factor on which the
indication of the need for transfusion is based.6,7
There is increasing evidence that transfusion is a
double-edged sword: untreated anemia can be
associated with a worse outcome and increased
mortality, whereas transfusion may cause various
infectious and non-infectious adverse effects.8–10 As
macrohemodynamic changes are not informative
enough, there is a clear need for additional quanti-
tative parameters that would give information on
anemia-related altered oxygen extraction and hence
the need for blood administration.7,11 One of the
potentially useful physiological parameters is the
central venous oxygen saturation (ScvO2). The ScvO2
has been found to be slightly higher than the mixed
venous oxygen saturation (SvO2), with normal
values 73–82%.12 Importantly, the ScvO2 closely
trends the changes in SvO2, and is considered a
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reasonable surrogate marker of mixed venous satu-
ration in the clinical setting.12 As such ScvO2, which
is easily measured at the bedside, has been found
reflect the balance between DO2 and VO2 in many
clinical settings.11,12
DO2 is dependent on in part of the concentration
of Hb. The value of using changes in ScvO2 to detect
anemia-related changes in oxygen balance in clinical
practice is still unclear. The aim of our study there-
fore was to monitor the changes of ScvO2 in isovo-
lemic anemia using a large animal model, and test
whether an altered VO2/DO2 balance, which is due
solely to a decreased Hb level, can be detected by
ScvO2.
Materials and methods
The study protocol was approved by the local ethics
committee at the University of Szeged, and the
study was carried out in the research laboratory of
the Institute of Surgical Research.
Animals and instrumentation
Vietnamese mini pigs (n = 13) weighing 24 3 kg
underwent a 24-h fast preoperatively but with
water ad libitum. Anesthesia was induced with an
intramuscular injection of a mixture of ketamine
(20 mg/kg) and xylazine (2 mg/kg) and main-
tained with a continuous infusion of propofol
(6 mg/kg/h i.v.). A tracheal tube was inserted and
the animals’ lungs were ventilated mechanically.
The tidal volume was set at 13  2 ml/kg, and the
respiratory rate was adjusted to maintain the end-
tidal carbon dioxide and the partial pressure of
arterial carbon dioxide in the range of 35–45 mmHg
(4.6–5.9 kPa) and the arterial pH between 7.35 and
7.45. The adequacy of the depth of anesthesia was
assessed by monitoring the jaw tone. After the ini-
tiation of anesthesia, the right carotid artery and
jugular vein and the right femoral artery and vein
were dissected and catheterized. The animals
underwent suprapubic urinary catheter placement
and laparotomy for splenectomy. Splenectomy in
swine hemorrhage models are performed because
of the distensibility of the spleen and the resultant
variation in the amounts of sequestered blood.13
The core temperature was maintained at 37  1 °C
through use of an external warming device.
For invasive hemodynamic monitoring, a
transpulmonary thermodilution catheter (PiCCO,
PULSION Medical Systems AG, Munich, Germany)
was placed in the femoral artery and a pulmonary
artery catheter (PV2057 VoLEF Catheter, PULSION
Medical Systems AG) by pressure tracings via the
femoral vein. The latter was also used to drawmixed
venous blood gas samples. The femoral artery
served as the site of arterial blood gas samples and
the central venous line was used for central venous
blood gas sampling and for the injection of cold
saline boluses for thermodilution measurements.
Central venous catheter was positioned by using
guidewire attached intracavital ECG. During the
experiment blood was drained from the catheter in
the right carotid artery, which was also used to
replace the blood loss with the same amount of
colloid, in order to avoid a sudden increase in right
ventricular preload.
Experimental protocol
The most important steps in the experiment are
outlined in Fig. 1. At baseline (T0) hemodynamic
and blood gas parameters were recorded, and
heparin sulfate (200 IU/kg) was administered
through the central venous line. Isovolemic anemia
was achieved in five intervals (T1–T5). During each
interval 10% of the estimated total blood volume
was withdrawn over a 5- to 10-min period. Hemo-
dynamic parameters were recorded and the amount
of blood drained off was immediately replaced by
an equal volume of colloid (hydroxyethyl starch
130 kDa/0.4, 6%, Voluven, Fresenius, Germany). To
achieve a steady state, the animals were allowed to
rest for 10 min between intervals. At the end of each
cycle, hemodynamic and blood gas parameters were
measured. At the end of the experiment the animals
were humanely euthanized.
Hemodynamic measurements
Cardiac output (CO), global end-diastolic volume,
intrathoracic blood volume, extravascular lung
water, stroke volume (SV), SV variation (SVV), index
of left ventricular contractility (dPmx), heart rate
(HR), andmean arterial pressure (MAP) were meas-
ured by transpulmonary thermodilution and pulse
contour analysis at baseline and at the end of each
interval. Detailed description of transpulmonary
thermodilution and pulse contour analysis are pro-
vided elsewhere.13,14 All hemodynamic parameters
were indexed for body surface area. The averages of
three random measurements following 10 ml bolus
injections of ice-cold 0.9% saline were recorded.
Continuous variables of invasive blood pressure
measurements and pulse contour analysis, such as
CO, MAP, HR, SV, SVV, and dPmx, were measured
and recorded at the end of each bleeding episode
and at the same times as the other hemodynamic
S. Kocsi et al.
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variables. The central venous pressure (CVP) was
determined by the pulmonary artery catheter at the
end of each bleeding episode and at the same times
as the other hemodynamic variables.
Arterial, central venous, and mixed venous blood
gas samples (Cobas b 221, Roche Ltd., Basel, Swit-
zerland) were drawn and analyzed by cooximetry
simultaneously at baseline and at the end of each
cycle (Fig. 1).
From these parameters the following variables
were calculated according to standard formulas:
DO SV HR Hb SaO PaO
CO CaO
2 2 2
2
1 34 0 003= ∗ ∗ ∗ ∗ + ∗( )[ ]
= ∗[ ]
. .
VO CO CaO Hb SvO
PvO CO CaO CvO
2 2 2
2 2 2
1 34
0 003
= ∗ − ∗ ∗([
+ ∗( ))] = ∗ −[ ]
.
.
Oxygen extraction VO DO CO CaO CvO
CO CaO
2 2 2 2
2 100
( ) = ∗ −[ ]
∗[ ]∗
Simplified oxygen extraction O ER
SaO ScvO SaO
2
2 2 2
( )
= −( )
Data analysis and statistics
Data are reported as medians (interquartile ranges)
or means standard deviations, unless indicated
otherwise. To test for normal distribution, the
Kolmogorov-Smirnov test was used. The changes in
all parameters throughout the experiment were
tested by repeated measures analysis of variance
(ANOVA); and the number of degrees of freedom
was adjusted to Greenhouse–Geisser epsilon when
needed. For pairwise comparisons, Pearson’s corre-
lation was used. To evaluate the performance of
ScvO2 in the detection of altered oxygen extraction
with a threshold of 30% of VO2/DO2, receiver oper-
ating characteristics (ROC) curve analysis was per-
formed, and sensitivity, specificity, and positive
predictive (PPV) and negative predictive values
(NPV) were also determined. To model the linear
relationship between VO2/DO2 and the possible
indicator of altered oxygen extraction, linear regres-
sion model was used. Post hoc calculation showed a
power of 86%with an effect of 25% increase in VO2/
DO2, for a sample size of 13 and a = 0.05. For statis-
tical analysis SPSS version 18.0 for Windows (SPSS,
Chicago, IL, USA) was used and P < 0.05 was con-
sidered statistically significant.
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Results
Hemodynamic effects of isovolemic anemia
All 13 animals survived the study. The blood loss
was on average 150  33 ml in each phase. Hemo-
dynamic data are presented in Table 1.
The bleeding caused a gradual decrease in Hb
level after each phase and by the end of the experi-
ment it had fallen by 61% of the baseline value. The
preload as indicated by global end-diastolic volume
index (GEDI), intrathoracic blood volume index
(ITBI), and CVP values did not change significantly.
HR, dPmx, and CI were increased significantly after
the first bleeding and remained so for the rest of the
experiment. Only CI changed significantly until T3
when comparing the values at each interval with the
previous one. MAP decreased significantly from T2,
but the median remained > 70 mmHg throughout.
Other macrohemodynamic variables did not change
significantly during the experiment.
Effects on oxygen balance
Variables relating to the oxygen balance are listed in
Table 2.
SaO2 remained in the normal range throughout
the experiment. DO2 fell significantly from T2, VO2 at
T4, VO2/DO2 increased significantly from T3, and
exceeded the physiologic threshold of 30%. The
change in ScvO2 displayed a similar pattern as VO2/
DO2 and changed significantly and also fell below
70% only at T4. The other parameters did not change
significantly. The pattern of changes of VO2/DO2
and ScvO2 over time is demonstrated in Fig. 2. Only
arterial oxygen partial pressure increased signifi-
cantly by the end of the experiment, other blood gas
parameters did not change significantly.
We determined the association between VO2/DO2
and ScvO2, and found a strong, negative correlation
(r = -0.71, P < 0.001) (Fig. 3).
ROC analysis revealed the same tendency as
the correlation. With 30% taken as the physiologic
threshold for VO2/DO2, the area under the
curve (AUC), its standard error and that of the 95%
confidence interval were > 0.5 for ScvO2 [AUC =
0.768  0.056 (0.657–0.878) P < 0.001]. It was also
important to determine the best cut-off for ScvO2 to
detect the significant increase in VO2/DO2, there-
fore, sensitivity, specificity, PPV, and NPV for ScvO2
levels of 70% and 75% were calculated. An ScvO2
level of 70% had better specificity and PPV, whereas
a ScvO2 level of 75% had better sensitivity and
NPV (sensitivity: 45%, specificity: 97%, PPV: 95,
NPV: 58; sensitivity: 68%, specificity: 77%, PPV:
79, NPV: 65, respectively). Furthermore, linear
regression revealed a significant relationship
between ScvO2 (r = 0.71, r2 = 0.50, P < 0.001) and
VO2/DO2.
Discussion
Maintaining adequate tissue oxygenation by
improving DO2 is the rational for blood transfusion.
Despite this fact, treatment of anemia with blood
transfusion in the absence of acute bleeding is rec-
ommended at certain levels of Hb, regardless of
actual DO2 and need, thus resulting in possible
Table 1
Hemodynamic effects of isovolemic anemia.
T0 T1 T2 T3 T4 T5
Hb (g/l) 125 (113–134) 102 (90–109)*† 79 (73–93)*† 68 (60–76)*† 59 (53–67)*† 49 (43–55)*†
(mmol/l) 7.7 (6.9–8.2) 6.3 (5.5–6.7) 4.8 (4.5–5.7) 4.2 (3.7–4.7) 3.6 (3.3–4.1) 3.0 (2.6–3.4)
HR (beats/min) 125 (91–135) 119 (100–138)* 123 (102–146)* 129 (110–159)* 139 (118–179)* 147 (131–177)*
MAP (mm Hg) 91 (79–105) 89 (79–101) 83 (75–98)* 82 (68–90)* 72 (59–85)* 72 (63–86)*
CVP (mm Hg) 6 (5–8) 8 (5–9) 7 (4–9) 7 (5–9) 7 (5–9) 7 (3–10)
CI (L/min/m2) 2.6 (2.3–2.8) 3.3 (2.7–3.6)*† 3.6 (2.9–3.8)*† 3.6 (3.3–4.1)* 3.5 (3.2–4.0)* 3.9 (3.6–4.1)*
GEDI (ml/m2) 270 (243–284) 271 (245–320) 276 (248–298) 274 (236–305) 268 (227–302) 261 (232–298)
ITBI (ml/m2) 335 (307–352) 335 (305–400) 343 (303–373) 342 (295–383) 334 (282–375) 333 (285–375)
ELWI (ml/kg) 9 (9–10) 10 (10–10) 9 (9–10) 10 (9–10) 10 (9–10) 10 (9–11)
SVI (ml/m2) 21 (18–29) 26 (23–31) 27 (24–31) 28 (25–31) 25 (21–33) 28 (22–31)
SVV (%) 17 (14–21) 15 (12–21) 19 (9–21) 15 (11–20) 19 (11–25) 14 (11–27)
dPmx (mm Hg/s) 540 (485–790) 700 (540–985)* 800 (570–1075)* 810 (540–1480)* 880 (560–1360)* 975 (562–1275)*
GLM repeated measures ANOVA.
*P < 0.05 compared with T0.
†P < 0.05 compared with previous.
Hb, hemoglobin; HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure; CI, cardiac index; GEDI, global
end-diastolic volume index; ITBI, intrathoracic blood volume index; ELWI, extravascular lung water index; SVI, stroke volume index;
SVV, stroke volume variation; dPmx, index of left ventricular contractility; T0, baseline measurement; T1–T5, five intervals of bleeding.
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excess blood administration.6,7 In our study in iso-
volemic anemia, we found that ScvO2 is a sensitive
indicator of oxygen balance and may thus serve as a
rational guide to therapy in this all too common
problem.
Oxygen balance and ScvO2
In certain clinical conditions, an ScvO2 value of
~70% has been used as a goal to therapeutic inter-
vention in attempts at improving DO2.15–18 In one
study in septic patients goal-directed therapy
Table 2
Effects of isovolemic anemia on oxygen balance.
T0 T1 T2 T3 T4 T5
SaO2 (%) 95 (92–97) 96 (94–97) 96 (95–97) 96 (95–97) 97 (97–97) 97 (97–97)
DO2 (ml/min/m2) 431 (362–474) 438 (323–524) 378 (302–412)*† 344 (252–376)* 284 (236–333)* 247 (216–292)*†
VO2 (ml/min/m2) 119 (82–139) 130 (77–151) 93 (66–136) 113 (67–141) 98 (72–120) 105 (70–120)
VO2/DO2 (%) 29 (18–33) 29 (17–33) 29 (18–32) 35 (21–40)* 37 (26–43)* 41 (27–47)*
ERO2 (%) 19 (13–26) 19 (14–24) 20 (14–22) 21 (16–28) 30 (22–37)* 32 (21–39)*
SvO2 (%) 68 (64–77) 67 (64–77) 68 (63–79) 64 (58–76) 62 (55–72)* 58 (52–72)*
ScvO2 (%) 76 (69–83) 73 (72 (82) 77 (75–83) 77 (68–81) 68 (61–76)* 66 (60–76)*
Lactate (mmol/l) 4.5 (3.2–5.3) 4.2 (3.0–5.1) 5.0 (3.2–6.0) 4.1 (2.9–6.0) 4.2 (2.9–6.5) 4.0 (3.0–6.4)
pH 7.44 (7.40–7.50) 7.43 (7.40–7.50) 7.43 (7.41–7.50) 7.43 (7.39–7.49) 7.44 (7.42–7.49) 7.44 (7.40–7.47)
PaO2 (mm Hg) 76 (66–80) 75 (72–80) 76 (73–80) 77 (72–82) 79 (75–85)* 81 (77–90)*
(kPa) 10.1 (8.8–10.7) 10.0 (9.6–10.7) 10.1 (9.7–10.7) 10.3 (9.6–10.9) 10.5 (10.0–11.3) 10.8 (10.3–12.0)
PaCO2 (mm Hg) 39 (35–44) 38 (35–43) 37 (34–45) 39 (34–46) 37 (34–42) 38 (35–41)
(kPa) 5.2 (4.7–5.9) 5.1 (4.7–5.7) 4.9 (4.5–6.0) 5.2 (4.5–6.1) 4.9 (4.5–5.6) 5.1 (4.7–5.5)
aHCO3 (mmol/l) 25 (24–27) 24 (24–26) 25 (23–27) 25 (23–27) 25 (22–27) 25 (21–25)
aBE (mmol/l) 0.90 (-0.05–2.50) 0.40 (-0.85–2.25) 0.60 (-0.9–2.45) 0.80 (-0.45–3.15) 0.90 (-1.45–2.35) 0.70 (0.43–1.08)
GLM repeated measures ANOVA.
*P < 0.05 compared with T0.
†P < 0.05 compared with previous.
SaO2, arterial oxygen saturation; DO2, oxygen delivery; VO2, oxygen consumption; VO2/DO2, oxygen extraction ratio; ERO2, simplified oxygen extraction
ratio; SvO2, mixed venous oxygen saturation; ScvO2, central venous oxygen saturation; PaO2, arterial oxygen partial pressure; PaCO2, arterial carbon
dioxide partial pressure; aHCO3, arterial bicarbonate; aBE, arterial base excess; T0, baseline measurement; T1–T5, five intervals of bleeding.
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Fig. 2. Changes of VO2/DO2 (A) and ScvO2 (B) over time (T0–T5). Data are presented as median (interquartile range). *P < 0.05 compared
with T0.
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according to ScvO2 values, saw an absolute 16%
reduction in in-hospital mortality as compared with
conventional therapy.15 Two recent studies have also
demonstrated that a low ScvO2 predicts peri- and
post-operative morbidity and complications in
high-risk surgery.16,17 It may also serve as a useful
tool to assist the weaning process in mechanically
ventilated patients.18
In our experiment, despite a continuous and sig-
nificant drop in Hb levels, the value of VO2/DO2
increased significantly only from T3, and exceeded
the physiologic threshold of 30%. The change in
ScvO2 displayed a similar pattern as VO2/DO2 and
fell below 70% only at T4. If we translate that into
clinical practice, the reduced Hb concentrations
could have indicated blood transfusion from T2;
however, we found no evidence of impaired VO2/
DO2 until the Hb was well below the current recom-
mended transfusion threshold.
About two decades ago it was found during hem-
orrhage in animal and human experimental models
that ScvO2 may be useful for the identification of
patients with occult or ongoing clinically significant
blood loss.19,20 In a prospective human interven-
tional study it was found that in acute isovolemic
anemia of Hb 50 g/l (3.1 mmol/l) in conscious
healthy resting humans did not produce evidence of
inadequate systemic DO2 and oxygen imbalance was
accompanied by a significant drop in SvO2.21 These
results were reinforced by a retrospective analysis of
a prospective observational study in which ScvO2
was found to be a good indicator of transfusion.22
Our results give further evidence that anemia-
induced change in oxygen balance can bemonitored
by ScvO2.
Hemodynamic effects of isovolaemic anemia
Our goal of maintaining isovolemia was achieved as
parameters of preload and central blood volume,
such as GEDI, ITBI, CVP did not change throughout
the experiment. A significant increase in cardiac
index was found, caused by increased HR, as SV did
not change significantly over time. This increase was
in agreement with the hemodynamic changes of a
recent study by Krantz et al. with a similar experi-
mental setting, but with a different hypothesis.23
Myocardial contractility as indicated by dPmx
values, also increased significantly, most likely in
response to isovolemic anemia. Although we did
not measure catecholamine levels, a theoretical
explanation could be that the bleeding caused an
enhanced stress response resulting in the observed
positive inotropic effect.24,25
Limitations of the study
One of the possible limitations of our study is that
the length of the preparation of the animals may
have been too long, which resulted in persistent
tachycardia and increased levels of lactate from
baseline to the end of the experiment. The steady-
state periods may also have been relatively short,
although, the same time intervals have been used
previously.26 Another concern might be the type of
fluid replacement, as one cannot exclude the possi-
bility that the use of different types of colloid solu-
tions would affect these results. Furthermore, these
data were obtained in anesthetized animals, and
may not be the same in conscious animals. Finally,
our results cannot be applied directly in those clini-
cal conditions where other confounding factors are
present, which may affect ScvO2, such as severe
sepsis, septic shock, multiple trauma, etc.
Conclusions
In conclusion, our results show that ScvO2 reflects
changes in oxygen extraction in isovolemic anemia.
Furthermore in isovolemic anemia, ScvO2 better
identifies the point when compensatory mecha-
nisms fail and DO2 begins to decline, as compared
with the Hb concentration alone. These findings are
in accord with the idea that compensatory changes
in CO and other parameters of DO2 make Hb con-
centration alone a less sensitive marker of oxygen
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Fig. 3. Correlation between VO2/DO2 and ScvO2. Data are pre-
sented as scatter with a linear regression line and its mean’s 95%
confidence interval. VO2/DO2: oxygen extraction, ScvO2: central
venous oxygen saturation.
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balance and for the need for therapeutic interven-
tion to increase DO2. ScvO2 could therefore be
important in helping to avoid hypoxia and tissue
injury under such circumstances, while helping to
more accurately guide blood transfusions. This
remains to be confirmed in the clinical setting.
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Monitoring hypovolemia is an everyday challenge in critical care, with no consensus on the best indicator or what is the clinically
relevant level of hypovolemia. The aim of this experiment was to determine how central venous oxygen saturation (ScvO
2
) and
central venous-to-arterial carbon dioxide difference (CO
2
gap) reflect hypovolemia-caused changes in the balance of oxygen
delivery and consumption. Anesthetized, ventilated Vietnamese minipigs (𝑛 = 10) were given a bolus followed by a continuous
infusion of furosemide. At baseline and then in five stages hemodynamic, microcirculatory measurements and blood gas analysis
were performed. Oxygen extraction increased significantly, which was accompanied by a significant drop in ScvO
2
and a significant
increase in CO
2
gap. There was a significant negative correlation between oxygen extraction and ScvO
2
and significant positive
correlation between oxygen extraction and CO
2
gap. Taking ScvO2 < 73% and CO2 gap >6mmHg values together to predict
an oxygen extraction >30%, the positive predictive value is 100%; negative predicted value is 72%. Microcirculatory parameters,
capillary perfusion rate and red blood cell velocity, decreased significantly over time. Similar changes were not observed in the
sham group. Our data suggest that ScvO2 < 73% and CO2 gap >6mmHg can be complementary tools in detecting hypovolemia-
caused imbalance of oxygen extraction.
1. Introduction
Diagnosing hypovolemia is an everyday challenge in critical
care. Clinicians utilize a large array of tools from simple
clinical signs to invasive hemodynamic measurements, but
a universally accepted gold standard remains elusive [1].
Although diagnosis may prove difficult, early recognition of
hypovolemia is of utmost importance. By the time macro-
hemodynamic changes manifest, the microcirculation may
already be damaged [2]. Furthermore, fluid therapy is a
double-edged sword: on the one hand fluid resuscitation can
save lives, but on the other hand a cumulative positive fluid
balance is an independent factor formortality [3, 4]. Deciding
on the level of monitoring (noninvasive, “less” invasive,
invasive) and which parameter to monitor in order to keep
the critically ill patient normovolemic remains uncertain.
Central venous oxygen saturation (ScvO
2
), an easily obt-
ained parameter via the central venous catheter already in
situ in most critically ill patients, is often used as a marker of
the balance between oxygen delivery (DO
2
) and consump-
tion (VO
2
). The main factors, which influence ScvO
2
, are
hemoglobin (Hb), arterial oxygen saturation (SaO
2
), cardiac
output (CO), andVO
2
.Theoretically ifHb, SaO
2
, andVO
2
are
kept constant, the value of ScvO
2
should reflect the change in
CO. Recent studies have translated theory into practice and
demonstrated that ScvO
2
may be a goodmarker for assessing
fluid responsiveness [5, 6].
The normal value of ScvO
2
varies between 73 and 82%.
It is slightly higher than mixed-venous oxygen saturation
(SvO
2
) and is considered a reasonable surrogate marker in
the clinical setting [7].
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Changes in ScvO
2
reflect systemic oxygen uptake butmay
be falsely positive (>70%) in regional hypoxia [8]. Under
these conditions the central venous-to-arterial CO
2
differ-
ence (CO
2
gap) has been proposed as an alternative [8–10].
The physiological value of CO
2
gap is <5mmHg, but this
may be higher in low-flow states [8, 9]. However, it remains
unclear how and whether the CO
2
gap changes in hypov-
olemia.
Therefore, the aim of our hypovolemic animal model was
to investigate the association between ScvO
2
, CO
2
gap, micr-
ocirculatory blood flow and hypovolemia-caused altered
VO
2
/DO
2
.
2. Methods
The study protocol was approved by the local Ethics Commit-
tee and the Institutional Animal Care and Use Committee at
the University of Szeged, and the study was conducted in the
research laboratory of the Institute of Surgical Research in a
manner that does not inflict unnecessary pain or discomfort
upon the animal.
2.1. Animals and Instrumentation. Vietnamese minipigs (𝑛 =
15) weighing 28 ± 4 kg underwent a 24 hr fast preoperatively
but with free access to water. Anesthesia was induced by
intramuscular injection of a mixture of ketamine (20mg/kg)
and xylazine (2mg/kg) and maintained with a continuous
infusion of propofol (6mg/kg/hr i.v.), while analgesia was
maintained with nalbuphine (0.1mg/kg). A tracheal tube was
inserted and the animals’ lungs were ventilated mechanically.
The tidal volume was set at 10mL/kg, and the respiratory
rate was adjusted to maintain the end-tidal carbon dioxide
and partial pressure of arterial carbon dioxide in the range
of 35–45mmHg and the arterial pH between 7.35 and 7.45.
The adequacy of the depth of anesthesia was assessed by
monitoring the jaw tone. After induction of anesthesia, the
right jugular vein and the right femoral artery and vein were
dissected and catheterized. Tonometric probes and catheters
were placed simultaneously into the stomach and the small
bowel. A suprapubic urinary catheter was also inserted to
monitor urine output. Animals were kept warm (35 ± 1∘C)
by an external warming device.
For invasive hemodynamic monitoring, a transpulmon-
ary thermodilution catheter (PiCCO, PULSION Medical
Systems SE, Munich, Germany) was placed in the femoral
artery, and a pulmonary artery catheter (PV2057 VoLEF
Catheter, PULSIONMedical Systems SE, Munich, Germany)
was placed in the femoral vein. The latter was also used
to draw mixed venous blood gas samples from which the
VO
2
was calculated. The femoral artery served as the site
for arterial blood gas sampling and the central venous line
was used for taking central venous blood gas samples and
for the injection of cold saline boluses for the thermodilution
measurements.
For continuous noninvasive visualization of the micro-
circulation in the sublingual region an intravital orthogonal
polarization spectral (OPS) imaging technique (Cytoscan
A/R, Cytometrics, Philadelphia, PA, USA) was used [2, 11].
A 10x objective was introduced onto the sublingual serosa,
and microscopic images were recorded with an S-VHS video
recorder (Panasonic AG-TL 700, Osaka, Japan).
For the tonometry special probes (Tonosoft Medical-
Technical and R&G Ltd.) were used and monitoring was per-
formed with a Sidestream Microcap Handheld Capnograph
(Oridion Medical Ltd., Jerusalem, Israel) instrument [12].
To assess further biochemical changes in the microcir-
culation, plasma big-endothelin-1 (BigET) levels were deter-
mined. BigET is a 38 amino acid containing protein, the
precursor of endothelin-1, which becomes elevated in tissue
hypoxia [13].
2.2. HemodynamicMeasurements. Cardiac output (CO), glo-
bal end-diastolic volume index (GEDI), stroke volume (SV),
heart rate (HR), andmean arterial pressure (MAP)weremea-
sured by transpulmonary thermodilution and pulse contour
analysis at baseline and at the end of each interval. Detai-
led description of transpulmonary thermodilution and pulse
contour analysis is provided elsewhere [14, 15]. All hemo-
dynamic parameters were indexed for body surface area or
bodyweight. The average of three measurements following
10mL bolus injections of ice-cold 0.9% saline was recorded.
Central venous pressure (CVP) was measured via the central
venous catheter at the same times as the other hemodynamic
variables.
Arterial, central venous, and mixed venous blood gas
samples (Cobas b 221, Roche Ltd., Basel, Switzerland) were
drawn and analyzed by cooximetry simultaneously at base-
line and at the end of each cycle.
2.3. Monitoring the Microcirculation. Microcirculatory eval-
uation of the sublingual region was performed offline by
frame-to-frame analysis of the videotaped images. Capillary
red blood cell velocity (RBCV) and capillary perfusion
rate (CPR) were determined in three separate fields using
a computer-assisted image analysis system (IVM Pictron,
Budapest, Hungary). All OPSmeasurements were performed
by one investigator.
Gastric and small bowel changes in partial pressure of car-
bon dioxide (ΔPCO
2
) were calculated by subtracting tono-
metric PCO
2
from arterial PCO
2
(gastric-arterial: Ga-PCO
2
;
bowel-arterial: Ba-PCO
2
) [12].
For measurements of BigET, blood samples of 2mL were
drawn from the jugular vein into chilled polypropylene tubes
containing EDTA (1mg/mL). The samples were centrifuged
at 1200 g for 10min at 4∘C. The plasma samples were then
collected and stored at −70∘C until assay.
2.4. Experimental Protocol. At baseline (T
0
) hemodynamic,
microcirculatory and blood gas parameters were recorded.
Hypovolemia was induced via a bolus followed by a con-
tinuous infusion of furosemide (5mg/kg and 5mg/kg/2 h,
resp.) in a group of 10 animals—hypovolemic group (HG).
After the administration of bolus furosemide measurements
were recorded in five stages with 20-minute interval between
each measurement (T
1
–T
5
). When the preload parameter
(GEDI) decreased by >20% its baseline value, OPS imaging
and BigET sampling were performed, which were repeated
only at the end of the experiment.There were 5 anaesthetised,
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Table 1: Hemodynamic changes.
𝑇
0
𝑇
1
𝑇
2
𝑇
3
𝑇
4
𝑇
5
GEDI (mL/m2) HG 349 ± 51 293 ± 53
∗‡# 257 ± 47∗‡# 246 ± 53∗# 233 ± 42∗# 223 ± 31∗#
SG 350 ± 26 387 ± 43 360 ± 22 365 ± 76 356 ± 51 349 ± 46
CVP (mmHg) HG 7 ± 4 4 ± 3
∗‡# 4 ± 3∗# 4 ± 3∗‡# 3 ± 3∗# 4 ± 3∗#
SG 8 ± 1 7 ± 1 7 ± 1 7 ± 2 7 ± 1 7 ± 2
MAP (mmHg) HG 121 ± 15 107 ± 17
∗‡ 94 ± 19∗‡ 86 ± 15∗‡ 85 ± 15∗ 83 ± 17∗
SG 120 ± 13 121 ± 14 117 ± 15 113 ± 16 121 ± 24 111 ± 25
HR (1/beats) HG 78 ± 14 83 ± 15
∗‡ 93 ± 17∗ 102 ± 19∗ 130 ± 28∗‡ 142 ± 28∗‡#
SG 74 ± 12 75 ± 12 74 ± 9 78 ± 10 83 ± 16 80 ± 9
CI (L/min/m2) HG 2.30 ± 0.35 1.78 ± 0.31
∗‡ 1.54 ± 0.32∗‡ 1.46 ± 0.35∗‡ 1.52 ± 0.41∗ 1.58 ± 0.36∗
SG 2.38 ± 0.50 2.65 ± 0.65 2.42 ± 0.48 2.38 ± 0.76 2.32 ± 0.50 2.27 ± 0.27
SVI (mL/m2) HG 29 ± 5 19 ± 2
∗‡# 15 ± 4∗# 14 ± 4∗# 12 ± 4∗# 12 ± 3∗#
SG 33 ± 4 34 ± 6 33 ± 3 32 ± 6 31 ± 8 28 ± 5
GEDI: global end-diastolic volume index; CVP: central venous pressure; MAP: mean arterial pressure; HR: heart rate; CI: cardiac index; SVI: stroke volume
index. 𝑇0: baseline measurement; 𝑇1–𝑇5: five intervals.
∗
𝑝 < .05 as compared to 𝑇1;
‡
𝑝 < .05 as compared to the previous value; RM ANOVA; #𝑝 < .05 HG
versus SG; Mann-Whitney 𝑈-test with Bonferroni correction.
ventilated animals in the sham group (SG), who did not
receive any furosemide, but maintenance infusion of lactated
Ringer (4mL/kg/h) and hemodynamic,microcirculatory and
blood gas parameters were recorded in the same fashion as
described previously. At the end of the experiment all animals
were humanely euthanized.
2.5. Data Analysis and Statistics. Data are reported as means
± standard deviations unless indicated otherwise. For test-
ing normal distribution the Kolmogorov-Smirnov test was
used. Changes in all parameters throughout the experi-
ment were tested by repeated measures analysis of variance
(RM ANOVA), and the number of degrees of freedom
was adjusted to Greenhouse-Geisser epsilon when needed.
Mann-Whitney U-test with Bonferroni correction was used
for between-groups analysis. For pairwise comparisons Pear-
son’s correlation was used. To evaluate the performance
of ScvO
2
, CO
2
gap and microcirculatory parameters in
detecting altered oxygen extraction with a threshold of 30%,
receiver operating characteristics (ROC) curve analysis was
performed, and sensitivity, specificity, positive predictive
(PPV), and negative predictive values (NPV) were also
determined. Post hoc calculation showed a power of 83%with
an effect of 36% decrease in GEDI for a sample size of 10
and 𝛼 = 0.05. For statistical analysis SPSS version 18.0 for
Windows (SPSS, Chicago, IL, USA) was used and 𝑝 < .05
was considered statistically significant.
3. Results
3.1. Hemodynamic Effects of Hypovolemia. Urine output in
the hypovolemic group following the bolus and the onset of
infusion was 176 ± 160mL at 𝑇
1
, which increased to 647 ±
231mL at 𝑇
5
. In contrast, in the sham group, urine output
was 74 ± 74mL at 𝑇
1
and had increased to 325 ± 175mL by
𝑇
5
. All other hemodynamic data are summarized in Table 1.
Preload, as indicated by GEDI, decreased significantly after
each phase in the hypovolemic group compared to baseline
and dropped by 36% of its baseline value by the end of the
experiment. The change of the other macrohemodynamic
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Figure 1: Correlation between VO
2
/DO
2
and ScvO
2
. Data are
presented as scatter with a linear regression line and its mean 95%
confidence interval. VO
2
/DO
2
: oxygen extraction, ScvO
2
: central
venous oxygen saturation.
variables followed a similar pattern. When comparing the
sham versus hypovolemic animals, variables differed between
the two groups from 𝑇
1
, but significant differences over time
continued only for GEDI, CVP and SVI. In the sham group
there were no significant changes over time throughout the
experiment.
3.2. Effects on Oxygen Balance. Variables related to oxygen
balance are listed in Table 2. In the hypovolemic group DO
2
fell significantly from 𝑇
1
and remained so for the rest of the
experiment. The VO
2
/DO
2
increased significantly over 30%
from 𝑇
1
, while ScvO
2
and CO
2
gap followed this change only
after 𝑇
2
. Lactate changed significantly from 𝑇
3
. There were
no significant changes in the sham group throughout the
experiment.
In the hypovolemic group there was a significant corre-
lation between VO
2
/DO
2
and ScvO
2
and CO
2
gap (Figures 1
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Table 2: Changes of oxygen balance.
𝑇
0
𝑇
1
𝑇
2
𝑇
3
𝑇
4
𝑇
5
SaO2 (%)
HG 94 ± 6 95 ± 5 95 ± 2 96 ± 2 94 ± 3 94 ± 2
SG 95 ± 5 94 ± 8 96 ± 5 94 ± 8 95 ± 5 94 ± 7
Hb (g/L) HG 122 ± 9 129 ± 13 132 ± 7
∗ 134 ± 7∗‡ 137 ± 7∗‡ 138 ± 8∗
SG 119 ± 10 115 ± 9 110 ± 6 108 ± 11 111 ± 9 102 ± 10
DO2I (mL/min/m
2) HG 361 ± 39 302 ± 52
∗‡ 268 ± 47∗‡ 258 ± 55∗ 269 ± 65∗ 284 ± 55∗
SG 365 ± 78 396 ± 88 346 ± 73 337 ± 67 324 ± 55 298 ± 36
VO2/DO2 (%)
HG 28 ± 5 31 ± 6∗‡ 34 ± 7∗‡ 39 ± 9∗‡ 41 ± 9∗ 40 ± 10∗
SG 25 ± 4 25 ± 6 26 ± 7 29 ± 5 27 ± 6 30 ± 7
ScvO2 (%)
HG 74 ± 10 71 ± 10 67 ± 11∗‡ 64 ± 14∗ 59 ± 13∗‡ 57 ± 14∗
SG 77 ± 8 76 ± 10 76 ± 9 75 ± 11 73 ± 14 73 ± 12
CO2-gap (mmHg)
HG 4.3 ± 2.3 7.5 ± 3.3 7.1 ± 2.6∗ 8.3 ± 2.8∗ 7.3 ± 2.9∗ 10.1 ± 5.5∗#
SG 4.1 ± 2.4 3.5 ± 1.9 4.5 ± 1.3 3.9 ± 2.9 4.6 ± 1.9 4.4 ± 1.9
Lactate (mmol/L) HG 3.8 ± 1.4 3.9 ± 1.3 4.3 ± 0.9 4.7 ± 0.9
∗‡ 5.1 ± 1.2∗‡ 5.3 ± 1.5∗
SG 3.8 ± 0.9 3.9 ± 1.2 4.2 ± 1.8 4.6 ± 2.1 4.7 ± 2.7 4.9 ± 3.2
VO2I (mL/min/m
2) HG 98 ± 11 93 ± 16 88 ± 9 96 ± 7
‡ 104 ± 10‡ 109 ± 16
SG 88 ± 16 96 ± 6 85 ± 12 96 ± 8 85 ± 12 88 ± 14
SaO2: arterial oxygen saturation; Hb: hemoglobin; DO2: oxygen delivery; VO2/DO2: oxygen extraction ratio; ScvO2: central venous oxygen saturation; CO2
gap: venous-to-arterial carbon dioxide difference; VO2: oxygen consumption. 𝑇0: baseline measurement; 𝑇1–𝑇5: five intervals.
∗
𝑝 < .05 as compared to 𝑇1;
‡
𝑝 < .05 as compared to the previous value; RM ANOVA; #𝑝 < .05HG versus SG; Mann-Whitney 𝑈-test with Bonferroni correction.
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Figure 2: Correlation between VO
2
/DO
2
and CO
2
gap. Data are
presented as scatter with a linear regression line and its mean 95%
confidence interval. VO
2
/DO
2
: oxygen extraction; CO
2
gap: central
venous-to-arterial carbon dioxide difference.
and 2). Lactate also showed a significant, but weak correlation
with VO
2
/DO
2
(𝑟 = .38, 𝑟2 = .14; 𝑝 < .05).
With receiver-operator characteristic (ROC) curves for
ScvO
2
, CO
2
gap and lactate to detect a VO
2
/DO
2
>30%, the
area under the curves (AUC) was significant for ScvO
2
, CO
2
gap (AUC ± SE = 0.887 ± 0.046; 0.783 ± 0.062; 𝑝 < .05,
resp.) while lactate did not reach statistical significance. The
cut-off values to give the best sensitivity and specificity for
ScvO
2
and CO
2
gap were 73% and 6.5mmHg, respectively.
Sensitivity, specificity, positive predictive, and negative pre-
dictive values for ScvO
2
and CO
2
gap are summarized in
Table 3: Complementation of ScvO2 with CO2 gap.
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
ScvO2 ≤ 73% 78 83 91 63
CO2 gap > 6mmHg 71 72 85 52
ScvO2 + CO2 gap
(≤73%) (>6mmHg) 58 100 100 72
ScvO2: central venous oxygen saturation; CO2 gap: venous-to-arterial car-
bon dioxide difference; PPV: positive redictive value; NPV: negative predic-
tive value.
Table 3. Taking ScvO
2
and CO
2
gap values together to predict
a VO
2
/DO
2
>30%, the false positive and false negative values
were reduced.
3.3. Effects on Microcirculation. Variables related to micro-
circulation are listed in Table 4. In the hypovolemic group
tonometry increased significantly only whenmeasured in the
intestines. Capillary perfusion rate and red blood cell velocity
gradually and significantly decreased over time. This change
was accompanied by a significant increase in BigET levels. In
contrast, the sham group BigET decreased significantly by𝑇
5
,
while the other parameters remained unchanged. There was
a significant difference in capillary perfusion rate, red blood
cell velocity and BigET between the two groups.
The ROC curves for predicting VO
2
/DO
2
>30% proved
to be significant for capillary perfusion rate and red blood cell
velocity in the hypovolemic group. The area under curve did
not differ significantly between these two parameters (AUC
± SE = 0.848 ± 0.084; 0.848 ± 0.092; 𝑝 < .05, resp.).
The correlation between ScvO
2
and the microcirculatory
parameters proved to be significant apart from Ga-PCO
2
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Table 4: Changes in microcirculation.
𝑇
0
𝑇
1
𝑇
2
𝑇
3
𝑇
4
𝑇
5
Ba-PCO2 (mmHg)
HG 24 ± 8 35 ± 16∗‡ 35 ± 17 36 ± 13∗ 33 ± 13∗ 37 ± 16∗
SG 19 ± 5 22 ± 9 20 ± 6 22 ± 11 22 ± 10 20 ± 8
Ga-PCO2 (mmHg)
HG 40 ± 12 43 ± 14 42 ± 14 39 ± 14 36 ± 10 37 ± 11
SG 36 ± 22 37 ± 24 34 ± 21 32 ± 21 34 ± 20 32 ± 18
CPR (%) HG 82 ± 15 — 53 ± 11
∗‡# — — 45 ± 16∗‡#
SG 91 ± 50 81 ± 80 83 ± 70
RBCV (𝜇m/s) HG 887 ± 141 — 509 ± 120
∗‡# — — 463 ± 209∗#
SG 1054 ± 141 848 ± 194 963 ± 51
BigET (fmol/mL) HG 1.44 ± 0.53 — 1.97 ± 0.84
∗‡ — — 2.29 ± 0.89∗#
SG 1.36 ± 0.93 1.49 ± 1.27 0.98 ± 0.92∗
Ba-PCO2: small bowel-to-arterial carbon dioxide difference; Ga-PCO2: gastric-to-arterial carbon dioxide difference; CPR: capillary perfusion rate; RBCV: red
blood cell velocity; BigET: big endothelin. 𝑇0: baseline measurement; 𝑇1–𝑇5: five intervals.
∗
𝑝 < .05 as compared to 𝑇1,
‡
𝑝 < .05 as compared to the previous
value, GLM repeated measures ANOVA; #𝑝 < .05HG versus SG, Mann-Whitney 𝑈-test with Bonferroni correction.
(ScvO
2
-Ba-PCO
2
, -CPR, -RBCV, -BigET: 𝑟 = −.38, 𝑟2 = .15;
𝑟 = .49, 𝑟2 = .24; 𝑟 = .40, 𝑟2 = .16; 𝑟 = −.47, 𝑟2 = .23;
𝑝 < .05, resp.). CO
2
gap showed significant correlations with
Ba-PCO
2
and CPR (𝑟 = .48, 𝑟2 = .23; 𝑟 = −.51, 𝑟2 = .26;
𝑝 < .05, resp.).
4. Discussion
The main finding of our study is that it provides further evi-
dence that low or decreasing ScvO
2
, as well as high or increas-
ing CO
2
-gap can reflect changes and may be complementary
in global oxygen balance and altered microcirculatory blood
flow in hypovolemia.
4.1. Hemodynamic Changes. Our goal of achieving hypov-
olemia was reached as global end diastolic index, central
venous pressure and stroke volume decreased significantly
throughout the experiment, which resulted in a significant
drop in cardiac index in the hypovolemia group. This
decrease was notable until 𝑇
3
. Due to this change VO
2
/DO
2
increased significantly from 𝑇
1
.
4.2. CO
2
Gap and ScvO
2
in Hypovolemia. Up until now,
there has been consensus neither on the most accurate
hemodynamic marker of hypovolemia nor on the endpoints
for optimal fluid therapy [1, 16, 17]. Many recent studies have
suggested that fluid therapy should be based on dynamic
(such as cardiac output, pulse pressure variation and stroke
volume variation) rather than static hemodynamic variables
(such as CVP, pulmonary artery occlusion pressure), because
they are better predictors of fluid responsiveness in ICU
patients. However, pulse pressure variation and stroke vol-
ume variation are limited to patients who are fully ventilated
and have no arrhythmias [18, 19]. Although it is not strictly
a hemodynamic variable, in certain clinical conditions an
ScvO
2
value of ∼70% has been used as a therapeutic endpoint
to improve oxygen delivery [3, 7, 20, 21]. In a recent study
it was found that a change in ScvO
2
is a reliable parameter
to define fluid responsiveness at the bedside in critically ill
patients [5]. Similar results have been reported in two other
studies demonstrating a close relationship between ScvO
2
and cardiac index [6, 22]. However, one has to bear in mind
that fluid resuscitation reduces hemoglobin levels, which
may result in no change or decrease in ScvO
2
therefore, the
above may only hold true for hypovolemic patients with low
ScvO
2
.
In our experiment the change in VO
2
/DO
2
, which incre-
ased significantly from 𝑇
1
, was accompanied by a fall in
ScvO
2
, which is in accordance with previous findings. The
change in VO
2
/DO
2
was also accompanied by an increase
in CO
2
gap from 𝑇
2
. There is some evidence that CO
2
gap
increases in certain low flow states [8, 9]. The pathophysiol-
ogy of increased CO
2
gap may be due to the CO
2
stagnation
phenomenon. When cardiac output decreases, blood flow is
slow and the washout is impaired; therefore, more CO
2
is
accumulated in the tissues, and as CO
2
diffuses easily and
quickly the CO
2
gap increases [23].
ScvO
2
showed very good sensitivity and specificity with
a threshold of 73% for determining VO
2
/DO
2
>30%, which
was further improved when CO
2
gap >6.5mmHg was added,
leading to less false negative and false positive results.
The ScvO
2
and CO
2
gap showed a significant and strong
negative correlation. It is also important to note that lactate
showed a significant but substantially weaker correlation to
VO
2
/DO
2
as compared to ScvO
2
or CO
2
gap. This highlights
the limitation of lactate levels as therapeutic endpoint for
resuscitation. This finding is in accordance with previously
published data showing the limitation of lactate levels as
therapeutic endpoint for resuscitation [24].
In cases when due to microcirculatory and/or mitochon-
drial defects oxygen uptake is insufficient, ScvO
2
may be
elevated (i.e. false negative). Previous studies have suggested
that under such circumstances the increased value of CO
2
gap
(>5mmHg) may help the clinician in detecting inadequate
DO
2
to tissues [8–10]. Our results lend further support to
this theory. Furthermore, adding the CO
2
gap to ScvO
2
for
identifying VO
2
/DO
2
>30%, there was an improvement in
specificity, positive predictive, and negative predictive values.
We are not aware of any studies that have tailored
hemodynamic support based on or supported by changes
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in CO
2
gap; therefore, its clinical relevance remains unclear.
However, our data clearly shows, and to our knowledge this
is the first experiment to show that, an altered VO
2
/DO
2
caused by hypovolemia is reflected by an increase in CO
2
gap. Therefore its value may be an important alarm signal
for the clinician and would help decision making at the
bedside, especially when considering a fluid challenge or
where commencing advanced hemodynamic monitoring is
concerned.
4.3. Microcirculation. In any shock like states the microcir-
culation plays a vital role, as the most devastating effects of
oxygen debt occur here in the cells [2, 22]. It has been demon-
strated thatmicrocirculatory disturbances can occur not only
in cases of severe hypovolemic shock, but also in cases of a
moderate hypovolemiawithout severe hypotension in human
patients [25]. Recently, Bartels et al. evaluated the alteration
of the sublingual microcirculation in response to controlled,
central hypovolemia using sidestream dark field imaging in
human subjects with intact autoregulation. They confirmed
that despite adequate compensation of hypovolemia it can
still be associated with decreased microcirculatory response,
consequently with decreased oxygen delivery to the tissues
[26].
In a prospective observational study in patients with
septic shock it was found that the capillary perfusion rate was
different in survivors (in whom it was increased) as com-
pared to nonsurvivors. Moreover, it was the only factor to
differentiate survivors and patients dying of multiple-system
organ failure after the shock had resolved [2]. In accordance
with these results we saw a gradual and significant decrease
in both capillary perfusion rate and red blood cell velocity
over time.There was also a very good area under curve when
defining VO
2
/DO
2
>30% and good correlation with ScvO
2
and CO
2
gap. All these changes were observed only in the
hypovolemic, but not in the sham group.
According to the microcirculatory parameters measured
in this experiment, the inflicted hypovolemia resulted in sig-
nificant changes to the microcirculation. Tonometry showed
a significant increase in Ba-PCO
2
due to hypovolemia, indi-
cating decreased blood flow in the intestines.This is in accor-
dance with previously published reports [27]. In contrast,
there was no significant change in the Ga-PCO
2
. Regarding
the importance and the value of gastric mucosal pH is
controversial and its routine use has declined in intensive care
over the last decades [28–30]. The difference between Ga-
PCO
2
and Ba-PCO
2
is an interesting observation and also
difficult to explain. However monitoring both has already
been suggested, in order to give a small additional value in
the diagnosis of possible mismatch in splanchnic perfusion
[31, 32].
There was also a significant correlation between Ba-PCO
2
both with ScvO
2
and CO
2
gap.
Little is known about BigET, but there is some evidence
that ET-1 reflects tissue hypoxia [33]. However, in contrast to
the insignificant change in BigET found in healthy volunteers
suffering from acute hypoxia, our results showed a significant
difference of BigET levels between the hypovolemic and
the sham groups, which indicates that there is an effect
of hypovolemia-induced tissue hypoxia on BigET levels
[34].
4.4. Limitations of the Study. One of the possible limitations
of our study is the long preparation period which might have
resulted in the slightly elevated lactate levels although thiswas
observed in both groups. Its clinical impact may be limited as
a decreased ScvO
2
and elevated CO
2
gap may be influenced
by several factors other than hypovolemia, including heart
failure, severe sepsis/septic shock, and multiple trauma; thus,
these results can only be applied when these conditions are
unlikely to be present, for example, in postoperative critical
care. Furthermore, these data were obtained in anesthetized
animals and may not be the same in conscious human
subjects. Finally, as there are no gold standards for hypo-
volemic animal experiments, therefore one cannot exclude
that the choice of furosemide-caused hypovolemia may not
be the most appropriate model. The disadvantage of this
model is that it does not replicate real life clinical diseases.
Traumatic hypovolemia and hypovolemia associated with
sepsis are associated with profoundmicrocirculatory changes
which become superimposed on the changes following
hypovolemia. This is particularly important in patients with
sepsis, where ScvO
2
is known to be a poor marker of tissue
oxygenation. Indeed, in patients with sepsis, a high rather
than a low ScvO
2
is predictive of mortality.
5. Conclusion
Our results have shown that in addition to central venous
oxygen saturation (ScvO
2
), central venous-to-arterial CO
2
difference (CO
2
gap) may also be used as a simple, but
valuable indicator of hypovolemia-caused imbalance of oxy-
gen extraction (VO
2
/DO
2
). Further clinical studies have
to validate its clinical merits in indicating and tailoring
hemodynamic support.
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Abstract
Despite blood transfusions are administered to restore adequate tissue oxygenation, transfusion guidelines consider only
hemoglobin as trigger value, which gives little information about the balance between oxygen delivery and consumption.
Central venous oxygen saturation is an alternative, however its changes reflect systemic metabolism and fail to detect
regional hypoxia. A complementary parameter to ScvO2 may be central venous-to-arterial carbon dioxide difference (CO2-
gap). Our aim was to investigate the change of alternative transfusion trigger values in experimental isovolemic anemia.
After splenectomy, anesthetized Vietnamese mini pigs (n = 13, weight range: 18–30 kg) underwent controlled bleeding in
five stages (T1–T5). During each stage approximately 10% of the estimated starting total blood volume was removed and
immediately replaced with an equal volume of colloid. Hemodynamic measurements and blood gas analysis were then
performed. Each stage of bleeding resulted in a significant fall in hemoglobin, the O2-extraction increased significantly from
T3 and ScvO2 showed a similar pattern and dropped below the physiological threshold of 70% at T4. By T4 CO2-gap
increased significantly and well correlated with VO2/DO2 and ScvO2. To our knowledge, this is the first study to show that
anemia caused altered oxygen extraction may have an effect on CO2-gap.
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Introduction
Transfusion of red blood cells is an everyday practice in critical
care with the primary aim of restoring adequate tissue oxygenation.
Transfusion guidelines consider certain levels of hemoglobin as
transfusion trigger [1,2], which on its own gives little information if
any about the balance between oxygen delivery (DO2) and
consumption (VO2). Hence, there is a clear need for additional
physiologic transfusion trigger values. One of the potentially useful
physiological parameters is the central venous oxygen saturation
(ScvO2), which has been shown to be a potential physiologic
transfusion trigger in hemodynamically stable but anemic patients
[3]. Its normal value is around 70–75% and it is the product of the
VO2 and DO2 relationship. Low ScvO2 usually indicates inade-
quate DO2, but higher than physiological values may be difficult to
interpret as these can indicate reduced oxygen consumption, but
may also mean inappropriate oxygen uptake [4,5]. Under these
circumstances additional parameters are needed.
Central venous-to-arterial carbon dioxide difference (CO2-gap)
may be one of the potential alternatives to complement ScvO2.
Under physiological circumstances its value is less than 6 mmHg
[6,7]. Transport of carbon dioxide in blood ensues in three forms:
dissolved in plasma, as bicarbonate ion and bound to hemoglobin.
The CO2-gap may be higher during anaerobic respiration when
lactic acid has to be buffered by bicarbonate or under aerobic
respiration in poorly perfused tissues when flow stagnation results in
an accumulation of CO2 [8,9,10]. From previous experiments it
seems that increased CO2-gap during ischemia is related to
decreased blood flow and impaired CO2 washout rather than to
hypoxemia [10]. Whether anemia caused tissue hypoxemia is
reflected in changes of the CO2-gap has not been investigated before.
Another additional parameter may be the central venous-to-arterial
pCO2 difference divided by the difference of the arterio-venous
oxygen content, P(v-a)CO2/C(a-v)O2, which is considered to give
information about tissue oxygenation. It was found in a retrospective
study that this ratio reflected the occurrence of anaerobic metabolism
better than other oxygen-, or CO2-derived parameters [11].
Our aim was to investigate how CO2-gap and P(v-a)CO2/C(a-
v)O2 change during experimental isovolemic anemia.
Materials and Methods
The study protocol was approved by the local ethics committee
at the University of Szeged and the study was carried out in the
research laboratory of the Institute of Surgical Research. The
current experiment complements our previously published data on
the relationship of ScvO2 and isovolemic anemia [12]. Vietnamese
mini pigs (n = 13) weighing 2463 kg were anaesthetized and
mechanically ventilated in pressure control mode. Anesthesia was
induced with an intramuscular injection of a mixture of ketamine
(20 mg/kg) and xylazine (2 mg/kg) and maintained with a
continuous infusion of propofol (6 mg/kg/h i.v.). The tidal volume
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was set at 1362 ml/kg and the respiratory rate was adjusted to
maintain the end-tidal carbon dioxide and the partial pressure of
arterial carbon dioxide in the range of 35–45 mmHg and the
arterial pH between 7.35 and 7.45. The adequacy of the depth of
anesthesia was assessed by monitoring the jaw tone. After the
initiation of anesthesia, the right carotid artery and jugular vein
and the right femoral artery and vein were dissected and
catheterized. The animals underwent suprapubic urinary catheter
placement and laparotomy for splenectomy. Splenectomy in swine
hemorrhage models are performed because of the distensibility of
the spleen and the resultant variation in the amounts of
sequestered blood [13]. The core temperature was maintained at
3761uC through use of an external warming device.
For invasive hemodynamic monitoring, a transpulmonary
thermodilution catheter (PiCCO, PULSION Medical Systems
AG, Munich, Germany) was placed in the femoral artery and a
pulmonary artery catheter (PV2057 VoLEF Catheter, PULSION
Medical Systems AG) by pressure tracings via the femoral vein.
The latter was also used to draw mixed venous blood gas samples.
The femoral artery served as the site of arterial blood gas samples
and the central venous line was used for central venous blood gas
sampling and for the injection of cold saline boluses for
Table 1. Hemodynamic effects of isovolemic anemia. These data have been published earlier [12].
T0 T1 T2 T3 T4 T5
Hb (g/L) 125(113–134) 102(90–109)*# 79(73–93)*# 68(60–76)*# 59(53–67)*# 49(43–55)*#
HR (beats/min) 125(91–135) 119(100–138)* 123(102–146)* 129(110–159) * 139(118–179) * 147(131–177)*
MAP (mm Hg) 91(79–105) 89(79–101) 83(75–98)* 82(68–90)* 72(59–85)* 72(63–86)*
CVP (mm Hg) 6(5–8) 8(5–9) 7(4–9) 7(5–9) 7(5–9) 7(3–10)
CI (L/min/m2) 2.6(2.3–2.8) 3.3(2.7–3.6)*# 3.6(2.9–3.8)*# 3.6(3.3–4.1)* 3.5(3.2–4.0)* 3.9(3.6–4.1)*
GEDI (mL/m2) 270 (243–284) 271 (245–320) 276 (248–298) 274 (236–305) 268 (227–302) 261 (232–298)
ELWI (mL/kg) 9 (9–10) 10 (10–10) 9 (9–10) 10 (9–10) 10 (9–10) 10 (9–11)
dPmx (mm Hg/s) 540(485–790) 700(540–985)* 800(570–1075)* 810(540–1480)* 880(560–1360)* 975(562–1275)*
Hb- Hemoglobin, HR- Heart rate, MAP- Mean arterial pressure, CVP- Central venous pressure, CI- Cardiac index, GEDI- Global end-diastolic volume index, ELWI-
extravascular lung water index, dPmx- Index of left ventricular contractility. T0- Baseline measurement, T1-T5- Five intervals of bleeding.
*p,.05 compared with T0 ;
#p,.05 compared with previous; GLM repeated measures ANOVA.
doi:10.1371/journal.pone.0105148.t001
Table 2. Descriptives (Median6IQR).
Time intervals
T0 T1 T2 T3 T4 T5
cvCO2-gap (mmHg) 5.0(2.6–8.5) 6.0(3.1–7.0) 5.0(3.5–5.5) 5.4(4.4–7.0) 8.0(4.3–8.5)* 6.3(5.9–11.0)*
vCO2-gap (mmHg) 5.5(4.0–9.0) 6.5(4.5–7.8) 6.5(5.1–7.0) 5.5(3.7–6.0) 5.4(5.0–8.0) 6.2(5.5–8.0)
PcvCO2/C(a-cv)O2 2.01(1.42–2.23) 2.27(1.76–3.34) 2.67(1.71–2.85) 2.59(1.50–4.47) 3.30(2.89–3.74)* 3.93(2.55–5.11)*
PvCO2/C(a-v)O2 1.57(0.77–1.99) 1.69(0.91–2.00) 1.71(1.36–1.99) 1.61(0.96–2.17) 2.14(1.58–2.23) 2.30(1.93–3.56)*
ScvO2 (%)
# 76(69–83) 73(72–82) 77(75–83) 77(68–81) 68(61–76)* 66(60–76)*
SvO2 (%)
# 68 (64–77) 67 (64–77) 68 (63–79) 64 (58–76) 62 (55–72)* 58 (52–72)*
DO2 (ml/min/m
2) # 431 (362–474) 438 (323–524) 378 (302–412)* 344 (252–376)* 284 (236–333)* 247 (216–292)*
VO2 (ml/min/m
2) # 119 (82–139) 130 (77–151) 93 (66–136) 113 (67–141) 98 (72–120)* 105 (70–120)*
VO2/DO2 (%)
# 29(18–33) 29(17–33) 29(18–32) 35(21–40)* 37(26–43)* 41(27–47)*
ERO2 (%)
# 19(13–26) 19(14–24) 20(14–22) 21(16–28) 30(22–37)* 32(21–39)*
Lactate (mmol/L) # 4.5 (3.2–5.3) 4.2 (3.0–5.1) 5.0 (3.2–6.0) 4.1 (2.9–6.0) 4.2 (2.9–6.5) 4.0 (3.0–6.4)
vLactate (mmol/L) 4.6(3.7–5.3) 4.3(3.3–5.3) 4.4(3.1–5.4) 4.4(2.8–5.2) 4.4(3.0–5.2) 4.1(3.0–6.4)
cvLactate (mmol/L) 4.5(3.5–5.5)1 3.9(3.4–5.4)1 4.2(3.3–6.3)1 4.1(3.1–5.6)1 3.9(2.9–5.7)1 3.9(3.0–6.4)1
PaCO2 (mmHg)
# 39(35–44) 38(35–45) 37(34–45) 39(34–46) 37(34–42) 38(35–41)
PaO2 (mmHg)
# 76(66–80) 75(72–80) 76(73–80) 77(72–82) 79(75–85) 81(77–90)
cvCO2-gap: central venous-to-arterial carbon dioxide difference; vCO2-gap: mixed venous-to-arterial carbon dioxide difference; P(cv-a)CO2/C(a-cv)O2: the central venous-to-
arterial pCO2 difference divided by the difference of the arterio-venous oxygen content; P(v-a)CO2/C(a-v)O2: the mixed venous-to-arterial pCO2 difference divided by the
difference of the arterio-venous oxygen content; ScvO2: central venous oxygen saturation; SvO2: mixed venous oxygen saturation; DO2: oxygen delivery; VO2: oxygen
consumption; VO2/DO2: oxygen extraction ratio; ERO2: simplified oxygen extraction ratio; PaCO2: arterial partial pressure of carbon dioxide; PaO2: arterial partial pressure
of oxygen * p,.05 as compared to baseline, 1 p,.05 significant difference between mixed venous and central venous blood with Friedman and Wilcoxon tests, # Data
published earlier [12].
doi:10.1371/journal.pone.0105148.t002
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thermodilution measurements. Central venous catheter was
positioned by using guidewire attached intracavital ECG. During
the experiment blood was drained from the catheter in the right
carotid artery, which was also used to replace the blood loss with
the same amount of colloid, in order to avoid a sudden increase in
right ventricular preload.
At baseline (T0) hemodynamic and blood gas parameters were
recorded, and heparin sulfate (200 IU/kg) was administered
through the central venous line. Isovolemic anemia was achieved
in five intervals (T1–T5). During each interval 10% of the estimated
total blood volume was withdrawn over a 5- to 10-min period.
Hemodynamic parameters were recorded and the amount of blood
drained was immediately replaced by an equal volume of colloid
(hydroxyethyl starch 130 kDa/0.4, 6%, Voluven, Fresenius,
Germany). To achieve a steady state, the animals were allowed to
rest for 10 min between intervals. At the end of each cycle,
hemodynamic and blood gas parameters were measured. At the end
of the experiment the animals were humanely euthanized.
Arterial, central venous, and mixed venous blood gas samples
(Cobas b 221, Roche Ltd., Basel, Switzerland) were drawn and
analyzed by cooximetry simultaneously at baseline and at the end
of each cycle. From these parameters the oxygen delivery (DO2),
oxygen consumption (VO2), oxygen extraction ratio (VO2/DO2)
and the simplified oxygen extraction ratio (ERO2) were calculated
according to standard formulae:
DO2~SV GR  Hb  1:34  SaO2z 0:003  PaO2ð Þ½ 
VO2~CO  CaO2{ Hb  1:34  SvO2z 0:003  PvO2ð Þð Þ½ 
ERO2~ SaO2{ScvO2ð Þ=SaO2
Central venous-to-arterial CO2-gap (cvCO2-gap), mixed venous-
to-arterial CO2-gap (vCO2-gap), the P(cv-a)CO2/C(a-cv)O2 and
P(v-a)CO2/C(a-v)O2 were also calculated from the arterial, central
venous and mixed venous blood gas samples.
These were calculated according to standard formulae:
cvCO2-gap~PcvCO2{PaCO2
vCO2-gap~PvCO2{PaCO2
P cv{að ÞCO2=C a{cvð ÞO2ratio~
PcvCO2{PaCO2ð Þ= CaO2{CcvO2ð Þ
P v{að ÞCO2=C a{vð ÞO2ratio~
PvCO2{PaCO2ð Þ= CaO2{CvO2ð Þ
CaO2~ 1:34  SaO2 Hbð Þz 0:003  PaO2ð Þ
CcvO2~ 1:34  ScvO2 Hbð Þz 0:003  PcvO2ð Þ
CvO2~ 1:34  SvO2 Hbð Þz 0:003  PvO2ð Þ
Analysis
Data are reported as median6standard deviation unless
indicated otherwise. For testing normal distribution the Kolmo-
gorov-Smirnov test was used. Changes in all parameters through-
out the experiment were tested by Friedman test and repeated
measures analysis of variance (RM ANOVA), and the number of
degrees of freedom was adjusted to Greenhouse-Geisser epsilon
when needed. For pairwise comparisons Pearson’s correlation was
used. To evaluate the performance in detecting altered oxygen
extraction of .30% (considered as the ‘‘physiological threshold’’),
receiver operating characteristics (ROC) curve analysis was
performed. Post-hoc calculation showed a power of 86% with an
effect of 25% increase in VO2/DO2, for a sample size of 13 and
a=0.05. For statistical analysis SPSS version 20.0 for Windows
(SPSS, Chicago, IL, USA) was used and p,0.05 was considered
statistically significant.
Results
All 13 animals survived the study. The bleeding caused a
gradual decrease in hemoglobin level after each phase and by the
end of the experiment it had fallen by 61% of the baseline value.
The hemodynamic parameters are summarized in Table 1. The
SaO2 remained in the normal range throughout the experiment.
DO2 fell significantly from T2, VO2 at T4, VO2/DO2 increased
significantly from T3, and exceeded the physiologic threshold of
30% (Table 2). The change in ScvO2 displayed a similar pattern
as VO2/DO2 and changed significantly and also fell below 70%
only at T4. There was strong negative correlation between VO2/
DO2 and ScvO2 (Fig. 1).
The CO2-gap was calculated for both, central venous (cvCO2-
gap) and mixed venous blood (vCO2-gap). By T4 cvCO2-gap
increased significantly, however vCO2-gap did not change. The
correlations of VO2/DO2 and ScvO2 were significant with cvCO2-
gap, while there were only weak correlations with vCO2-gap
(Fig. 2).
P(cv-a)CO2/C(a-cv)O2 increased by T4 and P(v-a)CO2/C(a-v)O2 by
T5. The correlations of VO2/DO2 and ScvO2 were significant
with P(cv-a)CO2/C(a-cv)O2, but it was found to be weak between
P(v-a)CO2/C(a-v)O2 and VO2/DO2, and there was no significant
correlation with ScvO2 (Fig. 3).
ROC analysis revealed the same tendency as the correlation.
With 30% taken as the physiologic threshold for VO2/DO2, the
area under the curve (AUC), its standard error and that of the
95% confidence interval were .0.5 only for cvCO2-gap,
P(cv-a)CO2/C(a-cv)O2 ratio, ScvO2 (Table 3.)
Figure 1. The association between VO2/DO2 and ScvO2. VO2/
DO2: oxygen extraction ratio; ScvO2: central venous oxygen
saturation.
doi:10.1371/journal.pone.0105148.g001
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Linear regression revealed a significant relationship between
ScvO2 (r = 0.71, r
2 = 0.50, p,.001) and VO2/DO2. This rela-
tionship became significantly stronger when cvCO2-gap was added
to ScvO2 (r = 0.74, r
2 = 0.54, p = .015). According to the Pratt’s
importance coefficient, ScvO2 was responsible for this increase in
63% and cvCO2-gap in 37%.
Discussion
Our results in this isovolemic anemia animal model show that
besides ScvO2, both central venous-to-arterial CO2-gap and the
P(cv-a)CO2/C(a-cv)O2 correlated well with changes in anemia
caused increase in VO2/DO2. Furthermore, mixed venous blood
driven indices, such as vCO2-gap and P(v-a)CO2/C(a-v)O2 failed to
indicate changes in oxygen extraction. When oxygen extraction
ratio started to increase (from T3) it was followed by a decrease of
ScvO2 and an increase of cvCO2-gap and P(cv-a)CO2/C(a-cv)O2,
and both performed well in the ROC analysis, with the cvCO2-
gap’s AUC being marginally better. In addition, in our experiment
neither vCO2-gap nor P(v-a)CO2/C(a-v)O2 or lactate could detect
the increase in VO2/DO2.30% as revealed by ROC analysis.
An interesting finding of our experiment is that despite
isovolemia was maintained as indicated by the stable global end
diastolic volume index values and there were in fact increasing
cardiac output and stroke volume, we observed a rise in cvCO2-
gap. This observation seemingly contradicts previously published
results to some extent. The occurrence of increased CO2-gap has
fundamentally been explained by the CO2 stagnation phenome-
non [5]. This was based on the finding that there was inverse
correlation between CO2-gap and cardiac index during non-septic
and septic low flow states [5,9,10]. Moreover, it was also found
that the amount of CO2 produced is negligible when anaerobic
respiration is present and CO2-gap therefore cannot serve as a
marker of tissue hypoxia [10]. The paramount study on this theory
by Vallet et al. used an isolated hind limb model and reached
hypoxia either by decreasing flow or decreasing arterial oxygen
content [10]. They found that occurrence of an increased CO2-
gap during ischemia was related to decreased blood flow and
impaired carbon dioxide washout; moreover, dysoxia per se was
Figure 2. Correlation between oxygen balance parameters and CO2-gap. cvCO2-gap and VO2/DO2 and ScvO2 (on the left); vCO2-gap and
VO2/DO2 and ScvO2 (on the right). cvCO2-gap: central venous-to-arterial carbon dioxide difference; VO2/DO2: oxygen extraction ratio; ScvO2: central
venous oxygen saturation; vCO2-gap: mixed venous-to-arterial carbon dioxide difference.
doi:10.1371/journal.pone.0105148.g002
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not sufficient to increase CO2-gap. However, the latter could also
be due to the Haldane’s effect. As the carbon dioxide dissociation
curve is influenced by the saturation of hemoglobin with oxygen,
the lower the saturation of hemoglobin with oxygen, the higher the
saturation of hemoglobin with carbon dioxide for a given carbon
dioxide partial pressure is [14]. In our experiment arterial oxygen
saturation and PaO2 remained in the normal range and did not
change over time, hence the CO2 dissociation curve was not
influenced by low saturation of hemoglobin with oxygen.
Nevertheless, anemia resulted in increased VO2/DO2 above the
baseline and also above the physiological 30% after the 3rd
bleeding event, which was followed by the significant decrease of
SvO2 and ScvO2. (It is important to note that there is
mathematical coupling between VO2 and SvO2, which is not
the case considering ScvO2). The most interesting finding of the
current study is the increase of cvCO2-gap during the last two
stages of the experiment, without any change in the vCO2-gap.
One of the possible reasons for this difference is that due to
isovolemia cardiac output was maintained to avoid low flow in the
systemic circulation, which is also reinforced by the unchanged
lactate levels. Therefore when CO2 was measured in the mixed
venous blood it was unchanged and within the normal range
Table 3. ROC analysis for determining VO2/DO2.30%.
Test Result Variable(s) Area Std. Error Sig. 95% CI
cvCO2-gap ,769 ,078 ,007 ,617 ,921
vCO2-gap ,553 ,097 ,598 ,363 ,742
P(cv-a)CO2/C(a-cv)O2 ratio ,742 ,070 ,016 ,604 ,879
P(v-a)CO2/C(a-v)O2 ratio ,641 ,096 ,157 ,453 ,829
ScvO2 ,768 ,056 ,000 ,657 ,879
SvO2 ,986 ,010 ,000 ,967 1,000
Lactate ,517 ,078 ,867 ,363 ,670
cvCO2-gap: central venous-to-arterial carbon dioxide difference;
vCO2-gap: mixed venous-to-arterial carbon dioxide difference;
P(cv-a)CO2/C(a-cv)O2: the central venous-to-arterial pCO2 difference divided by the difference of the arterio-venous oxygen content;
P(v-a)CO2/C(a-v)O2: the mixed venous-to-arterial pCO2 difference divided by the difference of the arterio-venous oxygen content;
ScvO2: central venous oxygen saturation; SvO2: mixed venous oxygen saturation.
doi:10.1371/journal.pone.0105148.t003
Figure 3. Correlation between tissue oxygenation and oxygen balance parameters. P(cv-a)CO2/C(a-cv)O2 and VO2/DO2 and ScvO2 (on the
left); P(v-a)CO2/C(a-v)O2 and VO2/DO2 and ScvO2 (on the right).P(cv-a)CO2/C(a-cv)O2: the central venous-to-arterial pCO2 difference divided by the
difference of the arterio-venous oxygen content; VO2/DO2: oxygen extraction ratio; ScvO2: central venous oxygen saturation; P(v-a)CO2/C(a-v)O2: the
mixed venous-to-arterial pCO2 difference divided by the difference of the arterio-venous oxygen content.
doi:10.1371/journal.pone.0105148.g003
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almost throughout. As central venous blood driven variables
mostly reflect blood flow and metabolism of the brain [15], our
hypothesis is that anemia reached such a degree by T4 that it
caused tissue hypoxia and consecutive anaerobic respiration with
CO2 production. However, due to the low hemoglobin levels the
Haldane effect could not take effect, hence there was a significant
increase in central venous pCO2. But these changes in the brain
did not have significant effects on the systemic level, to be picked
up in mixed venous blood. As anemia has greater influence on
arterial oxygenation than hypoxemia [16], this might explain the
observed increase in cvCO2-gap. This is further reinforced by the
P(cv-a)CO2/C(a-cv)O2 results. Both the P(cv-a)CO2/C(a-cv)O2 and the
P(v-a)CO2/C(a-v)O2 increased at T4 and T5, but there was a more
pronounced change in central venous as compared to mixed
venous blood, which is also reflected in the results of the ROC
analysis. We also measured mixed venous and central venous
lactate levels and found that central venous lactate was signifi-
cantly lower than in the mixed venous blood, which might give
further proof to this hypothesis [17,18]. In a previous animal
experiment by Hare et al, it was found that hemodilutional
isovolemic anemia led to cerebral hypoxia, and they also reported
a gradual increase in the jugular venous pCO2 with a CO2-gap of
2.9 to 7.8 mmHg (mean) 60 minutes after hemodilution in the
traumatic brain injured animals [19]. Although this finding was
not discussed in the article, as the authors mainly focused on
oxygenation, but nevertheless this is in accord with our results and
gives some support to our hypothesis.
There is increasing evidence that untreated anemia can be
associated with a worse outcome and increased mortality, while
transfusion may cause various infectious and non-infectious
adverse effects [20,21]. cvCO2-gap may be an additional
quantitative parameter, beyond Hb and ScvO2, that would give
information on anemia related altered oxygen extraction and
hence the need for blood administration. cvCO2-gap is a choice of
plausible alternatives as it can be easily obtained via the central
venous and arterial catheters already in situ in most critically ill
patients and no additional invasive device is needed; moreover we
found that mixed venous blood driven indices failed to indicate
changes in oxygen extraction.
There are several limitations of our study. As the experiment
was not designed to measure the effects of isovolemic anemia
specifically on the brain, our hypothesis cannot be supported by
specific measurements, such as regional cerebral blood flow,
cerebral tissue oxygen and carbon dioxide tension. Furthermore,
splenectomy and the length of the preparation of the animals may
have been too long, which resulted in increased levels of lactate
from baseline to the end of the experiment. The steady-state
periods may also have been relatively short, although, the same
time intervals have been used previously [22]. Another concern
might be the type of fluid replacement, as one cannot exclude the
possibility that the use of different types of colloid or crystalloid
solutions would affect these results.
Conclusions
To our knowledge, this is the first study to show that anemia
caused altered oxygen extraction may have an effect on cvCO2-gap
and P(cv-a)CO2/C(a-cv)O2 that cannot be detected from mixed
venous blood. The clinical relevance of this finding has to be
further tested in both experimental and clinical studies.
Acknowledgments
The authors would like to thank the assistants, medical students and staff at
the Institute of Surgical Research for their help.
Author Contributions
Conceived and designed the experiments: ZM SK. Performed the
experiments: JK DE´ GD SK. Analyzed the data: SK. Contributed
reagents/materials/analysis tools: JK DE´. Wrote the paper: ZM SK.
References
1. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, et al. British
Committee for Standards in Haematology (2013) Guidelines on the manage-
ment of anaemia and red cell transfusion in adult critically ill patients.
Br J Haematol 160(4):445–464.
2. Blood Observational Study Investigators of ANZICS-Clinical Trials Group,
Westbrook A, Pettila¨ V, Nichol A, Bailey MJ, Syres G, et al. (2010) Transfusion
practice and guidelines in Australian and New Zealand intensive care units.
Intensive Care Med 36: 1138–46.
3. Adamczyk S, Robin E, Barreau O, Fleyfel M, Tavernier B, et al. (2009)
Contribution of central venous oxygen saturation in postoperative blood
transfusion decision. Ann Fr Anesth Reanim 28: 522–30.
4. Vallet B, Robin E, Lebuffe G (2010) Venous oxygen saturation as a physiologic
transfusion trigger. Critical Care 14:213.
5. Valle´e F, Vallet B, Mathe O, Parraquette J, Mari A, et al. (2008) Central venous-
to-arterial carbon dioxide difference: an additional target for goal-directed
therapy in septic shock? Intensive Care Med 34:2218–2225.
6. Geers C, Gros G (2000) Carbon dioxide transport and carbonic anhydrase in
blood and muscle. Physiol Rev 80:681–715.
7. Guyton AC, Hall JE (2006) Transport of Oxygen and Carbon Dioxide in Blood
and Tissue Fluids. In: Guyton AC, Hall JE, editors. Textbook of Medical
Physiology. Eleventh Edition. Philadelphia, Elsevier Saunders, pp. 502–513.
8. Schlichtig R, Bowles SA (1994) Distinguishing between aerobic and anaerobic
appearance of dissolved CO2 in intestine during low flow. J Appl Physiol 76:
2443–2451.
9. Lamia B, Monnet X, Teboul JL (2006) Meaning of arterio-venous PCO2
difference in circulatory shock. Minerva Anestesiol 72:597–604.
10. Vallet B, Teboul JL, Cain S, Curtis S (2000) Venoarterial CO2 difference during
regional ischemic or hypoxic hypoxia. J Appl Physiol 89:1317–1321.
11. Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, et al.
(2002) Combination of venoarterial PCO2 difference with arteriovenous O2
content difference to detect anaerobic metabolism in patients. Intensive Care
Med 28:272–277.
12. Kocsi S, Demeter G, Fogas J, E´rces D, Kaszaki J, et al. (2012) Central venous
oxygen saturation is a good indicator of altered oxygen balance in isovolemic
anemia. ACTA Anaesthesiol Scand 56: 291–297.
13. Phillips CP, Vinecore K, Hagg DS, Sawai RS, Differding JA, et al. (2009)
Resuscitation of haemorrhagic shock with normal saline vs. lactated Ringer’s:
effects on oxygenation, extravascular lung water and haemodynamics. Critical
Care 13:R30.
14. West JB (1990) Gas transport to the periphery. In: West JB. Baltimore MD,
editor, Respiratory Physiology: The Essentials (4th ed.), Williams and Wilkins,
pp. 69–85.
15. Maddirala S, Khan A (2010) Optimizing hemodynamic support in septic shock
using central and mixed venous oxygen saturation. Crit Care Clin 26: 323–333.
16. Marino PL (2014) Systemic Oxygenation. In: Marino PL, editor, The ICU Book
(4th ed.) Wolters Kluwer Health/Lippincot Williams and Wilkins, pp. 171–192.
17. Jalloh I, Helmy A, Shannon RJ, Gallagher CN, Menon DK, et al. (2013) Lactate
uptake by the injured human brain: evidence from an arteriovenous gradient
and cerebral microdialysis study. J Neurotrauma 30(24): 2031–2037.
18. Gallagher CN, Carpenter KL, Grice P, Howe DJ, Mason A, et al. (2009) The
human brain utilizes lactate via the tricarboxylic acid cycle: a 13C-labelled
microdialysis and high-resolution nuclear magnetic resonance study. Brain
132(Pt10): 2839–2849.
19. Hare GM, Mazer CD, Hutchison JS, McLaren AT, Liu E, et al. (2007) Severe
hemodilutional anemia increases cerebral tissue injury following acute
neurotrauma. J Appl Physiol 103: 1021–9.
20. Vincent JL, Piagnerelli M (2006) Transfusion in the intensive care unit. Crit
Care Med 34: S96–S101.
21. Galvin I, Ferguson ND (2011) Acute lung injury in the ICU: focus on
prevention. In: Vincent JL, editor. Annual update in intensive care and
emergency medicine. Berlin: Springer Science+Business Media LLC. pp. 117–
28.
22. Meletti JFA, Mo´dolo NSP (2003) Hemorrhagic Shock Hemodynamic and
Metabolic Behavior: Experimental Study in Dogs. Revista Brasielira de
Anestesiologia 53: 623–632.
CO2-Gap in Isovolemic Anemia
PLOS ONE | www.plosone.org 6 August 2014 | Volume 9 | Issue 8 | e105148
